| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | helicase activity | 8.15e-06 | 158 | 214 | 10 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 9.37e-06 | 127 | 214 | 9 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.45e-05 | 37 | 214 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.14e-04 | 2 | 214 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | 3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity | 1.14e-04 | 2 | 214 | 2 | GO:0004119 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.14e-04 | 2 | 214 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | p53 binding | 1.78e-04 | 77 | 214 | 6 | GO:0002039 | |
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 1.88e-04 | 11 | 214 | 3 | GO:0043139 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO9A SPIRE1 CEP350 SPTBN5 DST KIF15 PLEKHM2 SUN2 CGN DMD CAMSAP2 USH2A TRIM2 VEZT LMOD2 PTPRT CCDC88A AFAP1 IRAG2 MACF1 DIXDC1 DAAM1 EP300 TTLL13 MX1 | 3.17e-04 | 1099 | 214 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 3.41e-04 | 3 | 214 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | microtubule binding | SPIRE1 CEP350 DST KIF15 SUN2 CGN CAMSAP2 CCDC88A IRAG2 MACF1 MX1 | 5.13e-04 | 308 | 214 | 11 | GO:0008017 |
| GeneOntologyMolecularFunction | DNA helicase activity | 5.32e-04 | 62 | 214 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.50e-04 | 262 | 214 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | zinc ion binding | NR2C2 MARCHF10 ZGRF1 ZCCHC2 TRIM29 TRIP12 ZPR1 KDM2B DMD TTF2 MYBBP1A TRIM2 SLC4A8 BAZ1B ERI2 CREBBP ZFAND4 IGHMBP2 PAM L3MBTL3 EP300 | 6.19e-04 | 891 | 214 | 21 | GO:0008270 |
| GeneOntologyMolecularFunction | tubulin binding | SPIRE1 CEP350 DST KIF15 SUN2 CGN CAMSAP2 CCDC88A IRAG2 MACF1 DIXDC1 TTLL13 MX1 | 7.52e-04 | 428 | 214 | 13 | GO:0015631 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.12e-03 | 5 | 214 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.40e-03 | 21 | 214 | 3 | GO:0042975 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 9.22e-05 | 9 | 220 | 3 | GO:0160064 | |
| Domain | DUF2012 | 5.80e-06 | 4 | 213 | 3 | PF09430 | |
| Domain | LRRC37AB_C | 5.80e-06 | 4 | 213 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 5.80e-06 | 4 | 213 | 3 | PF14914 | |
| Domain | DUF2012 | 5.80e-06 | 4 | 213 | 3 | IPR019008 | |
| Domain | LRRC37_N | 5.80e-06 | 4 | 213 | 3 | IPR032754 | |
| Domain | LRRC37 | 5.80e-06 | 4 | 213 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 5.80e-06 | 4 | 213 | 3 | IPR015753 | |
| Domain | Znf_FYVE_PHD | ATRX SPIRE1 ZFYVE9 KDM2B PCLO BAZ1B TAF3 BAZ1A ZFYVE19 RIMS1 | 7.36e-06 | 147 | 213 | 10 | IPR011011 |
| Domain | Spectrin_repeat | 1.75e-05 | 29 | 213 | 5 | IPR002017 | |
| Domain | - | 2.85e-05 | 6 | 213 | 3 | 3.90.1290.10 | |
| Domain | SNF2_N | 2.88e-05 | 32 | 213 | 5 | IPR000330 | |
| Domain | SNF2_N | 2.88e-05 | 32 | 213 | 5 | PF00176 | |
| Domain | SPEC | 2.88e-05 | 32 | 213 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.88e-05 | 32 | 213 | 5 | IPR018159 | |
| Domain | Plectin | 4.95e-05 | 7 | 213 | 3 | PF00681 | |
| Domain | Plectin_repeat | 4.95e-05 | 7 | 213 | 3 | IPR001101 | |
| Domain | Znf_GRF | 4.95e-05 | 7 | 213 | 3 | IPR010666 | |
| Domain | zf-GRF | 4.95e-05 | 7 | 213 | 3 | PF06839 | |
| Domain | PLEC | 4.95e-05 | 7 | 213 | 3 | SM00250 | |
| Domain | - | 7.73e-05 | 39 | 213 | 5 | 2.120.10.30 | |
| Domain | Carb-bd-like_fold | 7.85e-05 | 8 | 213 | 3 | IPR013784 | |
| Domain | Spectrin | 1.23e-04 | 23 | 213 | 4 | PF00435 | |
| Domain | ACTININ_2 | 1.23e-04 | 23 | 213 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.23e-04 | 23 | 213 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.23e-04 | 23 | 213 | 4 | IPR001589 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.29e-04 | 2 | 213 | 2 | IPR014744 | |
| Domain | ZnF_TAZ | 1.29e-04 | 2 | 213 | 2 | SM00551 | |
| Domain | L27_2 | 1.29e-04 | 2 | 213 | 2 | PF09045 | |
| Domain | - | 1.29e-04 | 2 | 213 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.29e-04 | 2 | 213 | 2 | IPR010303 | |
| Domain | - | 1.29e-04 | 2 | 213 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.29e-04 | 2 | 213 | 2 | PF09030 | |
| Domain | zf-TAZ | 1.29e-04 | 2 | 213 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.29e-04 | 2 | 213 | 2 | PS50134 | |
| Domain | KAT11 | 1.29e-04 | 2 | 213 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.29e-04 | 2 | 213 | 2 | IPR000197 | |
| Domain | KIX | 1.29e-04 | 2 | 213 | 2 | PF02172 | |
| Domain | HAT_KAT11 | 1.29e-04 | 2 | 213 | 2 | PF08214 | |
| Domain | KIX | 1.29e-04 | 2 | 213 | 2 | PS50952 | |
| Domain | WAC_Acf1_DNA_bd | 1.29e-04 | 2 | 213 | 2 | PF10537 | |
| Domain | CBP_P300_HAT | 1.29e-04 | 2 | 213 | 2 | IPR031162 | |
| Domain | DUF902 | 1.29e-04 | 2 | 213 | 2 | PF06001 | |
| Domain | WAC | 1.29e-04 | 2 | 213 | 2 | PS51136 | |
| Domain | LRP5/6 | 1.29e-04 | 2 | 213 | 2 | IPR017049 | |
| Domain | - | 1.29e-04 | 2 | 213 | 2 | 1.10.246.20 | |
| Domain | L27_2 | 1.29e-04 | 2 | 213 | 2 | IPR015132 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.29e-04 | 2 | 213 | 2 | IPR013178 | |
| Domain | WSTF_Acf1_Cbp146 | 1.29e-04 | 2 | 213 | 2 | IPR013136 | |
| Domain | KIX_dom | 1.29e-04 | 2 | 213 | 2 | IPR003101 | |
| Domain | CBP_P300_HAT | 1.29e-04 | 2 | 213 | 2 | PS51727 | |
| Domain | - | 1.58e-04 | 71 | 213 | 6 | 1.10.418.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.72e-04 | 46 | 213 | 5 | IPR011042 | |
| Domain | CH | 1.85e-04 | 73 | 213 | 6 | PS50021 | |
| Domain | Bromodomain_CS | 2.02e-04 | 26 | 213 | 4 | IPR018359 | |
| Domain | CH-domain | 2.14e-04 | 75 | 213 | 6 | IPR001715 | |
| Domain | DEXDc | 2.53e-04 | 109 | 213 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.68e-04 | 110 | 213 | 7 | IPR014001 | |
| Domain | CarboxyPept_regulatory_dom | 3.84e-04 | 13 | 213 | 3 | IPR014766 | |
| Domain | - | 3.84e-04 | 13 | 213 | 3 | 2.60.40.1120 | |
| Domain | BTP | 3.85e-04 | 3 | 213 | 2 | SM00576 | |
| Domain | BTP | 3.85e-04 | 3 | 213 | 2 | IPR006565 | |
| Domain | Bromo_TP | 3.85e-04 | 3 | 213 | 2 | PF07524 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 6.53e-04 | 35 | 213 | 4 | IPR002464 | |
| Domain | - | MARCHF10 ATRX SPIRE1 ZFYVE9 KDM2B TRIM2 PCLO BAZ1B TAF3 BAZ1A DZIP3 ZFYVE19 SCAF11 RIMS1 | 6.70e-04 | 449 | 213 | 14 | 3.30.40.10 |
| Domain | BROMODOMAIN_1 | 8.09e-04 | 37 | 213 | 4 | PS00633 | |
| Domain | Znf_RING/FYVE/PHD | MARCHF10 ATRX SPIRE1 ZFYVE9 KDM2B TRIM2 PCLO BAZ1B TAF3 BAZ1A DZIP3 ZFYVE19 SCAF11 RIMS1 | 8.29e-04 | 459 | 213 | 14 | IPR013083 |
| Domain | CH | 8.72e-04 | 65 | 213 | 5 | SM00033 | |
| Domain | CarboxyPept-like_regulatory | 8.84e-04 | 17 | 213 | 3 | IPR008969 | |
| Domain | Bromodomain | 8.96e-04 | 38 | 213 | 4 | PF00439 | |
| Domain | DEAH_ATP_HELICASE | 8.96e-04 | 38 | 213 | 4 | PS00690 | |
| Domain | ZF_ZZ_2 | 1.05e-03 | 18 | 213 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 1.05e-03 | 18 | 213 | 3 | PS01357 | |
| Domain | ZZ | 1.05e-03 | 18 | 213 | 3 | PF00569 | |
| Domain | BROMODOMAIN_2 | 1.20e-03 | 41 | 213 | 4 | PS50014 | |
| Domain | CH | 1.22e-03 | 70 | 213 | 5 | PF00307 | |
| Domain | Znf_ZZ | 1.24e-03 | 19 | 213 | 3 | IPR000433 | |
| Domain | ZnF_ZZ | 1.24e-03 | 19 | 213 | 3 | SM00291 | |
| Domain | DDT | 1.27e-03 | 5 | 213 | 2 | SM00571 | |
| Domain | DDT_dom | 1.27e-03 | 5 | 213 | 2 | IPR018501 | |
| Domain | Perilipin | 1.27e-03 | 5 | 213 | 2 | PF03036 | |
| Domain | WHIM1_dom | 1.27e-03 | 5 | 213 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 1.27e-03 | 5 | 213 | 2 | IPR028941 | |
| Domain | WSD | 1.27e-03 | 5 | 213 | 2 | PF15613 | |
| Domain | WHIM1 | 1.27e-03 | 5 | 213 | 2 | PF15612 | |
| Domain | FATC | 1.27e-03 | 5 | 213 | 2 | PF02260 | |
| Domain | Perilipin | 1.27e-03 | 5 | 213 | 2 | IPR004279 | |
| Domain | Bromodomain | 1.31e-03 | 42 | 213 | 4 | IPR001487 | |
| Domain | BROMO | 1.31e-03 | 42 | 213 | 4 | SM00297 | |
| Domain | - | 1.31e-03 | 42 | 213 | 4 | 1.20.920.10 | |
| Domain | Helicase_C | 1.42e-03 | 107 | 213 | 6 | PF00271 | |
| Domain | HELICc | 1.42e-03 | 107 | 213 | 6 | SM00490 | |
| Domain | Helicase_C | 1.49e-03 | 108 | 213 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 1.57e-03 | 109 | 213 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.57e-03 | 109 | 213 | 6 | PS51192 | |
| Domain | PDEase_I | 1.67e-03 | 21 | 213 | 3 | PF00233 | |
| Domain | PDEASE_I | 1.67e-03 | 21 | 213 | 3 | PS00126 | |
| Domain | PDEase_CS | 1.67e-03 | 21 | 213 | 3 | IPR023174 | |
| Domain | PDZ | 1.76e-03 | 151 | 213 | 7 | PS50106 | |
| Domain | PDZ | 1.82e-03 | 152 | 213 | 7 | IPR001478 | |
| Domain | BRK | 1.88e-03 | 6 | 213 | 2 | SM00592 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS | 1.09e-05 | 5 | 147 | 3 | M48304 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 ATRX MYO9A USP11 ZGRF1 LIN54 ZCCHC2 SGO1 KIF15 NOMO2 ANAPC1 KDM2B MPP1 EP400 TTC28 ELP1 BAZ1B AASDH MAP7 CREBBP CCDC88A RBM6 MACF1 CGNL1 CRYBG3 PATJ LRIF1 PCM1 TP53BP1 HDLBP | 1.94e-18 | 588 | 222 | 30 | 38580884 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 PDE3B MYO9A MPDZ SPIRE1 TRIP12 CEP350 NEK4 USP31 DST CGN ZBTB21 NHS PLEKHA5 CAMSAP2 ABTB2 WNK3 BICC1 ARAP2 DYRK2 CCSER1 EDC3 TTC28 RALGAPB MAP7 RFX7 CCDC88A MACF1 CGNL1 CRYBG3 PATJ PCM1 | 1.15e-15 | 861 | 222 | 32 | 36931259 |
| Pubmed | MYO9A MPDZ CEP350 DST NHS PLEKHA5 CAMSAP2 CEP97 EDC3 TTC28 ARHGEF12 MAP7 CCDC88A AFAP1 MACF1 CRYBG3 PCM1 | 3.54e-14 | 209 | 222 | 17 | 36779422 | |
| Pubmed | NR2C2 ZGRF1 LIN54 DST KIF15 ANAPC1 ZBTB21 ATF7IP2 KDM2B PLEKHA5 CHD6 NPAT COL6A1 SIN3B TTC28 CHD8 NUP214 CCDC88A GTF3C2 CRYBG3 L3MBTL3 PCM1 | 4.62e-14 | 418 | 222 | 22 | 34709266 | |
| Pubmed | SMG1 NCOA6 NACA SPIRE1 SNRK DST ZBTB21 KDM2B PLEKHA5 SDK2 EP400 CHD8 SMG5 ERI2 CCDC88A AFAP1 GTF3C2 PCNX1 SCAF11 DIXDC1 DAAM1 ESPL1 L3MBTL3 | 6.43e-13 | 529 | 222 | 23 | 14621295 | |
| Pubmed | SMG1 NCOA6 NR2C2 ATRX USP11 LIN54 NACA TAF8 DST ZBTB21 KDM2B SLX4IP CHD6 NPAT SIN3B MYBBP1A EDC3 EP400 ARID4A BAZ1B CHD8 SMG5 NUP214 MAP7 RFX7 CREBBP TAF3 GTF3C2 RBM6 LRP6 SCAF11 L3MBTL3 LRIF1 EP300 PCM1 TP53BP1 | 1.95e-12 | 1429 | 222 | 36 | 35140242 | |
| Pubmed | DNAJB12 SP3 ATRX NACA IST1 MPDZ SPIRE1 TAF8 DST ANAPC1 SUN2 KDM2B ALDH18A1 CHD6 CAMSAP2 SIN3B STRN3 EDC3 EP400 RALGAPB ARHGEF12 BAZ1B CHD8 DDX51 MAP7 NOMO1 AFAP1 GTF3C2 BAZ1A IGHMBP2 RBM6 MACF1 SCAF11 DAAM1 PATJ HDLBP | 7.35e-12 | 1497 | 222 | 36 | 31527615 | |
| Pubmed | NCOA6 MPDZ ANAPC1 CGN KDM2B PLEKHA5 TTF2 SIN3B MYBBP1A EP400 TTC28 BAZ1B CHD8 CREBBP TAF3 GTF3C2 PATJ EP300 PLIN3 PCM1 TP53BP1 HDLBP | 1.03e-11 | 549 | 222 | 22 | 38280479 | |
| Pubmed | SMG1 NCOA6 CNKSR1 ATRX TRIM29 TRIP12 ZBED5 ZNF518A THAP2 DST ZFYVE9 CHD6 TTF2 CREBBP NOMO1 BAZ1A LRP5 MACF1 DAAM1 PLIN3 NOMO3 HDLBP | 4.25e-11 | 591 | 222 | 22 | 15231748 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 ATR ATRX TRIP12 ANAPC1 ZBTB21 KDM2B STRN3 MYBBP1A EP400 ARID4A RALGAPB BAZ1B DDX51 NUP214 RFX7 TAF3 RBM6 SCAF11 RIMS1 ESPL1 PCM1 TP53BP1 HDLBP | 2.22e-10 | 774 | 222 | 24 | 15302935 |
| Pubmed | MYO9A EVPL CEP350 RGL1 DST PLEKHA5 CHD6 DMD CHD8 NUP214 CREBBP USF3 CCDC88A IRAG2 MACF1 BICRAL CGNL1 EP300 HDLBP | 4.25e-10 | 486 | 222 | 19 | 20936779 | |
| Pubmed | MPDZ ITIH4 CNTNAP5 DST KIF15 ANAPC1 ZBTB21 NGEF PLEKHA5 CAMSAP2 WNK3 CNTN4 SIN3B STRN3 MYBBP1A SLC4A8 ARHGEF12 CHD8 CCDC88A DZIP3 MACF1 DIXDC1 RIMS1 UBASH3B PCM1 TP53BP1 | 7.21e-10 | 963 | 222 | 26 | 28671696 | |
| Pubmed | 1.62e-09 | 4 | 222 | 4 | 9267806 | ||
| Pubmed | SMG1 NCOA6 SNRK ZNF518A DST PLEKHA5 CHD6 TTC28 RALGAPB CHD8 SMG5 MACF1 PCNX1 | 2.67e-09 | 225 | 222 | 13 | 12168954 | |
| Pubmed | SMG1 NCOA6 CNKSR1 LRRC37A3 CEP350 NEK4 THAP2 KDM2B CHD6 VTN TTC28 ELP1 DDX51 REV3L LMOD2 CREBBP ZFAND4 ABCC6 EP300 NOMO3 | 6.37e-09 | 638 | 222 | 20 | 31182584 | |
| Pubmed | SMG1 PDE3B ATR ATRX NACA MPDZ FREM2 DST PLEKHA5 DDX11L8 VTN TTC28 RALGAPB ELP1 CHD8 AIFM2 CCDC88A PAM CRYBG3 PATJ | 8.69e-09 | 650 | 222 | 20 | 38777146 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA6 NR2C2 LIN54 KDM2B EP400 ARID4A BAZ1B CHD8 NUP214 RFX7 CREBBP TAF3 BAZ1A LRIF1 EP300 | 9.57e-09 | 351 | 222 | 15 | 38297188 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | ATRX MPDZ NGEF C3 CHD6 SIN3B MYBBP1A EDC3 ARHGEF12 CHD8 SMG5 NUP214 DZIP3 NFAT5 PCM1 TP53BP1 HDLBP | 1.34e-08 | 475 | 222 | 17 | 31040226 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NR2C2 ATRX LIN54 SGO1 TRIP12 ZBTB21 KDM2B CHD6 NPAT SIN3B ARID4A BAZ1B CHD8 TAF3 GTF3C2 BAZ1A SCAF11 LRIF1 ZNF292 | 1.63e-08 | 608 | 222 | 19 | 36089195 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NCOA6 NR2C2 ATR ATRX LIN54 TRIP12 DST ANAPC1 SUN2 KDM2B CHD6 TTF2 SIN3B MYBBP1A EP400 ARID4A BAZ1B DDX51 NUP214 MAP7 RFX7 GTF3C2 BAZ1A SCAF11 L3MBTL3 LRIF1 EP300 C1orf174 | 1.93e-08 | 1294 | 222 | 28 | 30804502 |
| Pubmed | DNAJB12 MYO9A MPDZ DST ALDH18A1 PLEKHA5 TTF2 MYBBP1A EDC3 TTC28 ARHGEF12 NUP214 CCDC88A LRP6 MACF1 CRYBG3 PATJ PLIN3 EPHA3 HDLBP | 3.56e-08 | 708 | 222 | 20 | 39231216 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NR2C2 USP11 TRO LIN54 TRIM29 TRIP12 ANAPC1 ZBTB21 TTF2 SIN3B EP400 ARID4A AGGF1 THUMPD1 SMG5 REV3L CREBBP GTF3C2 BAZ1A L3MBTL3 EP300 TP53BP1 | 3.88e-08 | 857 | 222 | 22 | 25609649 |
| Pubmed | NCOA6 PDE3A ZGRF1 TRIP12 DST FAM186A NGEF DMD MYBBP1A SDK2 MACF1 CGNL1 | 4.14e-08 | 234 | 222 | 12 | 36243803 | |
| Pubmed | DNAJB12 NACA MPDZ CEP350 NEK4 NOMO2 ANAPC1 PLEKHA5 CHD6 MPP1 EDC3 TANK EP400 TTC28 VEZT NUP214 CCDC88A PATJ ESPL1 PCM1 | 6.25e-08 | 733 | 222 | 20 | 34672954 | |
| Pubmed | TRO IST1 USP31 PLEKHM2 CHD6 CAMSAP2 ARAP2 EP400 TTC28 RALGAPB ARHGEF12 NUP214 DZIP3 MACF1 NFAT5 | 6.72e-08 | 407 | 222 | 15 | 12693553 | |
| Pubmed | ATRX TRIP12 SUN2 CHD6 CEP97 MYBBP1A EP400 TTC28 CHD8 NUP214 TAF3 GTF3C2 BAZ1A SCAF11 L3MBTL3 TP53BP1 | 7.01e-08 | 469 | 222 | 16 | 27634302 | |
| Pubmed | DNAJB12 NR2C2 PDE3B ATRX USP11 MPDZ USP31 NOMO2 SUN2 PLEKHA5 NPAT MYBBP1A VEZT RALGAPB ELP1 BAZ1B MAP7 NOMO1 SLC5A3 AIFM2 CCDC88A GTF3C2 MACF1 CRYBG3 DAAM1 ESPL1 PCM1 TP53BP1 HDLBP | 9.80e-08 | 1487 | 222 | 29 | 33957083 | |
| Pubmed | SGO1 TRIP12 CEP350 DST C3 CHD6 EP400 TTC28 ARID4A MAP7 CREBBP GTF3C2 DZIP3 L3MBTL3 LRIF1 EP300 PLIN3 PCM1 | 2.11e-07 | 645 | 222 | 18 | 25281560 | |
| Pubmed | MPDZ NEK4 DST ANAPC1 CGN ALDH18A1 PLEKHA5 TTF2 STRN3 EDC3 TTC28 RALGAPB ELP1 PATJ PCM1 | 2.18e-07 | 446 | 222 | 15 | 24255178 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 NR2C2 ATRX LIN54 TRIP12 SLX4IP NPAT MYBBP1A EP400 ARID4A BAZ1B CHD8 NUP214 TAF3 BAZ1A RBM6 SCAF11 L3MBTL3 PCM1 TP53BP1 C1orf174 HDLBP | 2.45e-07 | 954 | 222 | 22 | 36373674 |
| Pubmed | USP11 TRIP12 DST ANAPC1 CGN ALDH18A1 MYBBP1A ELP1 BAZ1B CHD8 DDX51 NUP214 RBM6 MACF1 SCAF11 PCM1 TP53BP1 HDLBP | 2.52e-07 | 653 | 222 | 18 | 22586326 | |
| Pubmed | 2.57e-07 | 3 | 222 | 3 | 36011023 | ||
| Pubmed | p300/CREB-binding protein interacts with ATR and is required for the DNA replication checkpoint. | 2.57e-07 | 3 | 222 | 3 | 17272271 | |
| Pubmed | 2.57e-07 | 3 | 222 | 3 | 9590171 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.57e-07 | 3 | 222 | 3 | 25576386 | |
| Pubmed | BDP1 CLTCL1 ZNF559 VSIG4 EVPL SNRK THAP2 RGL1 SERPINA1 DST CGN ZBTB21 C3 TRIM2 ELP1 REV3L SLC5A3 AIFM2 GTF3C2 SLC16A4 LRP6 DAAM1 ESPL1 PCM1 TP53BP1 HDLBP | 2.67e-07 | 1293 | 222 | 26 | 15342556 | |
| Pubmed | NCOA6 NACA DST ALDH18A1 PLEKHA5 CEP97 TTF2 STRN3 EP400 CHD8 AFAP1 BAZ1A MACF1 CRYBG3 TP53BP1 | 4.47e-07 | 472 | 222 | 15 | 38943005 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATRX NACA IST1 DST ZBTB21 CAMSAP2 TTF2 SIN3B STRN3 MYBBP1A EDC3 EP400 BAZ1B NUP214 BAZ1A MACF1 CGNL1 PLIN3 PCM1 TP53BP1 HDLBP | 7.01e-07 | 934 | 222 | 21 | 33916271 |
| Pubmed | 8.35e-07 | 157 | 222 | 9 | 30186101 | ||
| Pubmed | USP11 ITIH4 ZNF518A TAF8 ANAPC1 SUN2 ZBTB21 CRNN ARAP2 EP400 TTC28 VEZT BAZ1B CHD8 REV3L MAP7 CREBBP TAF3 MACF1 BICRAL CRYBG3 EP300 PCM1 | 9.04e-07 | 1116 | 222 | 23 | 31753913 | |
| Pubmed | CNKSR1 PDE3A TRIM29 TRIP12 NHS PLEKHA5 STRN3 MYBBP1A EDC3 CHD8 MAP7 GTF3C2 RBM6 PCM1 TP53BP1 | 9.89e-07 | 503 | 222 | 15 | 16964243 | |
| Pubmed | 1.02e-06 | 4 | 222 | 3 | 22419166 | ||
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.02e-06 | 4 | 222 | 3 | 31833031 | |
| Pubmed | 1.02e-06 | 4 | 222 | 3 | 8954775 | ||
| Pubmed | 1.02e-06 | 4 | 222 | 3 | 9194565 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SMG1 ATRX USP11 TRIP12 ANAPC1 MYBBP1A EP400 ELP1 CHD8 NUP214 GTF3C2 RBM6 ESPL1 TP53BP1 | 1.07e-06 | 440 | 222 | 14 | 34244565 |
| Pubmed | 1.08e-06 | 83 | 222 | 7 | 28794006 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.33e-06 | 123 | 222 | 8 | 26912792 | |
| Pubmed | ATRX ZNF518A ZBTB21 SLX4IP EP400 REV3L CREBBP MCM9 RBM6 LRIF1 | 1.84e-06 | 222 | 222 | 10 | 37071664 | |
| Pubmed | CLTCL1 USP11 LIN54 NOMO2 KDM2B NPAT SIN3B MYBBP1A EP400 CHD8 L3MBTL3 LRIF1 | 2.16e-06 | 339 | 222 | 12 | 30415952 | |
| Pubmed | 2.54e-06 | 5 | 222 | 3 | 10362258 | ||
| Pubmed | 2.54e-06 | 5 | 222 | 3 | 11912212 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | ATRX NACA CEP350 SERPINA1 SLX4IP ALDH18A1 EDC3 EP400 CHD8 NUP214 LRIF1 HDLBP | 3.66e-06 | 357 | 222 | 12 | 37059091 |
| Pubmed | 5.06e-06 | 6 | 222 | 3 | 16734381 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | NR2C2 USP11 LIN54 SUN2 ZBTB21 TTF2 SIN3B MYBBP1A EP400 ARID4A CHD8 GTF3C2 BAZ1A NFAT5 TP53BP1 | 5.95e-06 | 583 | 222 | 15 | 29844126 |
| Pubmed | 6.17e-06 | 151 | 222 | 8 | 17043677 | ||
| Pubmed | 6.47e-06 | 152 | 222 | 8 | 34299191 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | NACA KIF15 PLEKHA5 SIN3B MYBBP1A NUP214 MAP7 CCDC88A PCM1 HDLBP | 6.53e-06 | 256 | 222 | 10 | 33397691 |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 6.74e-06 | 109 | 222 | 7 | 33554859 | |
| Pubmed | 8.82e-06 | 75 | 222 | 6 | 25593309 | ||
| Pubmed | 9.74e-06 | 268 | 222 | 10 | 33640491 | ||
| Pubmed | 1.02e-05 | 116 | 222 | 7 | 30804394 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NR2C2 USP11 ZNF518A KDM2B TTF2 COL6A1 EP400 PCLO CREBBP BICRAL EP300 ZNF292 | 1.10e-05 | 398 | 222 | 12 | 35016035 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 BDP1 PDE3B ATRX MYO9A SPIRE1 PVR NGEF SLX4IP CHD6 VEZT RALGAPB CREBBP USF3 RBM6 LRP5 MACF1 SCAF11 RIMS1 DAAM1 PATJ NFAT5 EP300 PCM1 CPNE7 | 1.11e-05 | 1489 | 222 | 25 | 28611215 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 1.40e-05 | 8 | 222 | 3 | 15257293 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PDE8A ATRX SPIRE1 NEK4 CGN ZBTB21 CRNN PLEKHA5 C3 CAMSAP2 CEP97 RSPH10B DYRK2 MYBBP1A VTN EDC3 MAP7 CREBBP NOMO1 CCDC88A GTF3C2 DZIP3 TP53BP1 | 1.44e-05 | 1321 | 222 | 23 | 27173435 |
| Pubmed | SGO1 CEP350 USP31 ZFYVE9 KIF15 SUN2 CGN ALDH18A1 NHS DMD MYBBP1A VEZT RALGAPB ELP1 PTPRT CCDC88A LRP6 CRYBG3 L3MBTL3 HDLBP | 1.49e-05 | 1049 | 222 | 20 | 27880917 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYO9A USP11 FRMD7 SGO1 TRIM29 ZBED5 PLIN2 PLEKHM2 SLX4IP ALDH18A1 ABTB2 ARAP2 ARID4A RALGAPB ELP1 BAZ1B DDX51 SLC16A4 IRAG2 SCAF11 MX1 C1orf174 | 1.72e-05 | 1242 | 222 | 22 | 30973865 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | LIN54 NACA SGO1 TRIM29 BCLAF3 CEP350 SERPINA1 ANAPC1 ALDH18A1 CEP97 NAA16 STRN3 MYBBP1A EDC3 AGGF1 NUP214 GTF3C2 DIXDC1 ESPL1 PCM1 TP53BP1 | 1.84e-05 | 1155 | 222 | 21 | 20360068 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | IST1 EVPL TRIM29 DST CGN NHS PLEKHA5 ARHGEF12 NUP214 MACF1 DAAM1 PATJ PLIN3 HDLBP | 1.85e-05 | 565 | 222 | 14 | 25468996 |
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | SMG1 MYO9A USP31 FAM186A ATF7IP2 CHD6 AASDH TEK PTPRT PCNX1 DIXDC1 EPHA3 | 1.87e-05 | 420 | 222 | 12 | 28065597 |
| Pubmed | USP31 DST ZFYVE9 NHS PLEKHA5 DMD RALGAPB NOMO1 CCDC88A MACF1 DAAM1 EPHA3 | 1.91e-05 | 421 | 222 | 12 | 36976175 | |
| Pubmed | SMG1 CLTCL1 ATRX TTC16 TRO LIN54 STOX1 SGO1 TRIP12 DST FAM186A ZBTB21 CHD6 DMD CAMSAP2 KIAA2012 STRN3 MYBBP1A PCLO BAZ1A MACF1 RIMS1 USPL1 ZNF292 | 1.93e-05 | 1442 | 222 | 24 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO9A USP11 NACA TRIP12 ZBED5 DST ALDH18A1 AP1G2 PLEKHA5 TTF2 MYBBP1A EP400 ELP1 BAZ1B CHD8 DDX51 NUP214 CREBBP GTF3C2 BAZ1A MACF1 TP53BP1 HDLBP | 2.09e-05 | 1353 | 222 | 23 | 29467282 |
| Pubmed | 2.10e-05 | 9 | 222 | 3 | 16801560 | ||
| Pubmed | The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. | 2.10e-05 | 9 | 222 | 3 | 16488880 | |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 2.10e-05 | 9 | 222 | 3 | 36261522 | |
| Pubmed | 2.13e-05 | 130 | 222 | 7 | 12421765 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | SMG1 IST1 TRIP12 DST SUN2 MYBBP1A EDC3 PCLO NUP214 ZFYVE19 MACF1 PLIN3 HDLBP | 2.16e-05 | 498 | 222 | 13 | 36634849 |
| Pubmed | Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. | 2.85e-05 | 92 | 222 | 6 | 10493829 | |
| Pubmed | 2.98e-05 | 10 | 222 | 3 | 23064749 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 2.98e-05 | 10 | 222 | 3 | 15345741 | |
| Pubmed | 2.98e-05 | 10 | 222 | 3 | 20347598 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | USP11 CEP350 ANAPC1 SUN2 USH2A CNTN4 STRN3 SDK2 AGGF1 CREBBP NOMO1 CCDC88A SCAF11 NOMO3 TP53BP1 | 3.02e-05 | 670 | 222 | 15 | 22990118 |
| Pubmed | NACA TRIM29 ITIH4 KDM2B ULK4 CHD6 DMD EP400 BAZ1B NUP214 CREBBP ADGB IRAG2 RBM6 EP300 HDLBP | 3.12e-05 | 754 | 222 | 16 | 35906200 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NR2C2 LIN54 ZBTB21 SLX4IP CEP97 EDC3 EP400 BAZ1B CHD8 CREBBP L3MBTL3 HDLBP | 3.21e-05 | 444 | 222 | 12 | 34795231 |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 4.06e-05 | 2 | 222 | 2 | 34845315 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 26132276 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 19729597 | ||
| Pubmed | Dissecting molecular differences between Wnt coreceptors LRP5 and LRP6. | 4.06e-05 | 2 | 222 | 2 | 21887268 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 23172129 | ||
| Pubmed | PAR1&2 driven placenta EVT invasion act via LRP5/6 as coreceptors. | 4.06e-05 | 2 | 222 | 2 | 33136328 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 11002341 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 39287984 | ||
| Pubmed | LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. | 4.06e-05 | 2 | 222 | 2 | 15084453 | |
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 31706332 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 20717166 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 19017980 | ||
| Pubmed | 4.06e-05 | 2 | 222 | 2 | 25893291 | ||
| Interaction | GSK3A interactions | NR2C2 MYO9A TTC16 LRRC37A2 MPDZ CEP350 DST NHS PLEKHA5 CAMSAP2 CEP97 EDC3 TANK TTC28 ARHGEF12 MAP7 RFX7 CCDC88A AFAP1 LRP6 MACF1 CRYBG3 PCM1 | 1.28e-09 | 464 | 217 | 23 | int:GSK3A |
| Interaction | PHF21A interactions | SP3 ZGRF1 DST KIF15 ANAPC1 KDM2B PLEKHA5 CHD6 NPAT SIN3B TTC28 CHD8 NUP214 CCDC88A DZIP3 CRYBG3 L3MBTL3 PCM1 | 3.69e-08 | 343 | 217 | 18 | int:PHF21A |
| Interaction | KDM1A interactions | NR2C2 ZGRF1 LIN54 CEP350 DST KIF15 ANAPC1 ZBTB21 ATF7IP2 KDM2B AP1G2 PLEKHA5 CHD6 NPAT COL6A1 SIN3B EDC3 EP400 TTC28 CHD8 NUP214 CCDC88A GTF3C2 DZIP3 CRYBG3 UBASH3B L3MBTL3 EP300 PCM1 TP53BP1 | 1.01e-07 | 941 | 217 | 30 | int:KDM1A |
| Interaction | WWTR1 interactions | NCOA6 MPDZ ANAPC1 CGN PLEKHA5 TTF2 SIN3B MYBBP1A EP400 TTC28 CHD8 CREBBP GTF3C2 PATJ EP300 PLIN3 PCM1 TP53BP1 HDLBP | 1.70e-07 | 422 | 217 | 19 | int:WWTR1 |
| Interaction | FEV interactions | NCOA6 NR2C2 ATRX LIN54 TAF8 KDM2B CHD6 EP400 CREBBP TAF3 GTF3C2 L3MBTL3 EP300 | 3.26e-07 | 203 | 217 | 13 | int:FEV |
| Interaction | YWHAH interactions | NCOA6 PDE3B MYO9A MPDZ SPIRE1 TRIP12 CEP350 USP31 DST CGN ZBTB21 NHS PLEKHA5 CAMSAP2 WNK3 BICC1 ARAP2 CCSER1 EDC3 TTC28 RALGAPB MAP7 RFX7 CREBBP CCDC88A MACF1 RIMS1 CGNL1 CRYBG3 PATJ PCM1 | 9.27e-07 | 1102 | 217 | 31 | int:YWHAH |
| Interaction | HNF4A interactions | NCOA6 NR2C2 ATRX LIN54 ZBTB21 KDM2B SLX4IP DMD EP400 CREBBP TAF3 GTF3C2 L3MBTL3 EP300 | 1.81e-06 | 275 | 217 | 14 | int:HNF4A |
| Interaction | YWHAQ interactions | NCOA6 PDE3A PDE3B MYO9A USP11 SPIRE1 TRIP12 CEP350 USP31 SERPINA1 DST CGN ZBTB21 ULK4 NHS PLEKHA5 CAMSAP2 BICC1 ARAP2 CCSER1 VTN EDC3 TTC28 MAP7 RFX7 CCDC88A BAZ1A MACF1 CGNL1 PCM1 | 3.67e-06 | 1118 | 217 | 30 | int:YWHAQ |
| Interaction | YWHAG interactions | NCOA6 PDE3B MYO9A MPDZ SPIRE1 TRIP12 CEP350 NEK4 USP31 DST KIF15 CGN ZBTB21 NHS PLEKHA5 CAMSAP2 CEP97 BICC1 ARAP2 CCSER1 EDC3 TTC28 RALGAPB MAP7 RFX7 CCDC88A BAZ1A MACF1 SCAF11 CGNL1 PATJ PCM1 | 4.35e-06 | 1248 | 217 | 32 | int:YWHAG |
| Interaction | H2BC8 interactions | NR2C2 ATRX LIN54 SGO1 TRIP12 KDM2B CHD6 TRMT5 EP400 ARID4A BAZ1B CHD8 GTF3C2 BAZ1A SCAF11 L3MBTL3 LRIF1 PLIN3 ZNF292 C1orf174 | 4.54e-06 | 576 | 217 | 20 | int:H2BC8 |
| Interaction | FBXO42 interactions | BDP1 MYO9A KIF15 ANAPC1 EP400 TTC28 ELP1 MAP7 CCDC88A MACF1 CRYBG3 PCM1 HDLBP | 4.98e-06 | 259 | 217 | 13 | int:FBXO42 |
| Interaction | SUMO2 interactions | ATRX USP11 NACA TRIP12 DST ANAPC1 ZBTB21 SLX4IP TANK EP400 BAZ1B CHD8 NUP214 GTF3C2 BAZ1A SCAF11 USPL1 EP300 TP53BP1 HDLBP | 6.65e-06 | 591 | 217 | 20 | int:SUMO2 |
| Interaction | C2CD4B interactions | 7.30e-06 | 44 | 217 | 6 | int:C2CD4B | |
| Interaction | MAPRE3 interactions | CEP350 NEK4 DST KIF15 PLEKHA5 CAMSAP2 CCSER1 TTF2 TTC28 MAP7 CCDC88A MACF1 | 7.83e-06 | 230 | 217 | 12 | int:MAPRE3 |
| Interaction | SLX4 interactions | ATRX NACA ZNF518A CEP350 SERPINA1 ZBTB21 SLX4IP ALDH18A1 EDC3 EP400 CHD8 NUP214 REV3L CREBBP MCM9 RBM6 LRIF1 TP53BP1 HDLBP | 1.48e-05 | 572 | 217 | 19 | int:SLX4 |
| Interaction | CAMSAP2 interactions | CEP350 CGN ZBTB21 PLEKHA5 CAMSAP2 MAP7 CREBBP MACF1 ESPL1 PCM1 | 1.53e-05 | 169 | 217 | 10 | int:CAMSAP2 |
| Interaction | NR3C1 interactions | SMG1 NCOA6 CNKSR1 LRRC37A3 PLIN2 CEP350 NEK4 THAP2 KDM2B ALDH18A1 C3 CHD6 STRN3 VTN TTC28 ELP1 DDX51 NUP214 REV3L LMOD2 CREBBP ZFAND4 ABCC6 LRIF1 EP300 NOMO3 | 1.90e-05 | 974 | 217 | 26 | int:NR3C1 |
| Interaction | SFN interactions | NCOA6 MYO9A SPIRE1 TRIP12 CEP350 NEK4 USP31 DST CGN ZBTB21 NHS PLEKHA5 CAMSAP2 ARAP2 CCSER1 EDC3 CCDC88A ZFYVE19 MACF1 CGNL1 CRYBG3 | 2.01e-05 | 692 | 217 | 21 | int:SFN |
| Interaction | GSK3B interactions | MYO9A NACA MPDZ TRIP12 CEP350 DST NHS PLEKHA5 CHD6 CAMSAP2 CEP97 DYRK2 MPP1 EDC3 TANK TTC28 ARHGEF12 MAP7 CCDC88A AFAP1 LRP6 MACF1 CRYBG3 PCM1 | 2.31e-05 | 868 | 217 | 24 | int:GSK3B |
| Interaction | RCOR1 interactions | ZGRF1 DST ANAPC1 ZBTB21 KDM2B PLEKHA5 CHD6 NPAT SIN3B TTC28 ARID4A CHD8 CCDC88A DZIP3 L3MBTL3 PCM1 TP53BP1 | 2.71e-05 | 494 | 217 | 17 | int:RCOR1 |
| Interaction | H3C3 interactions | NR2C2 ATRX LIN54 SGO1 TRIP12 KDM2B CHD6 NPAT SIN3B ARID4A BAZ1B CHD8 GTF3C2 BAZ1A SCAF11 LRIF1 ZNF292 | 2.78e-05 | 495 | 217 | 17 | int:H3C3 |
| Interaction | GOLGA1 interactions | 3.05e-05 | 183 | 217 | 10 | int:GOLGA1 | |
| Interaction | YWHAZ interactions | BDP1 NR2C2 PDE3B MYO9A SPIRE1 TRIP12 NEK4 USP31 DST KIF15 CGN ZBTB21 NHS PLEKHA5 C3 CAMSAP2 ARAP2 CCSER1 EDC3 TTC28 RALGAPB MAP7 CCDC88A IRAG2 ZFYVE19 MACF1 SCAF11 CGNL1 EP300 PCM1 TP53BP1 | 3.42e-05 | 1319 | 217 | 31 | int:YWHAZ |
| Interaction | MAPRE1 interactions | CEP350 NEK4 IGSF10 DST PLEKHA5 CAMSAP2 CEP97 CCSER1 VEZT BAZ1B NUP214 MAP7 CCDC88A AFAP1 MACF1 EP300 PCM1 | 4.45e-05 | 514 | 217 | 17 | int:MAPRE1 |
| Interaction | NUP43 interactions | NCOA6 NR2C2 LIN54 SGO1 TRIP12 ZNF518A DST NGEF CHD6 DNAH9 NPAT EP400 ARID4A CHD8 NUP214 TAF3 CCDC88A BAZ1A ZNF292 | 4.95e-05 | 625 | 217 | 19 | int:NUP43 |
| Interaction | KLF16 interactions | NR2C2 LIN54 KDM2B NPAT SIN3B MYBBP1A EP400 BAZ1B MAP7 TAF3 SCAF11 L3MBTL3 LRIF1 EP300 HDLBP | 6.12e-05 | 425 | 217 | 15 | int:KLF16 |
| Interaction | HDAC1 interactions | NR2C2 SP3 ATR ATRX USP11 ZGRF1 DST KIF15 ZBTB21 KDM2B PLEKHA5 NPAT SIN3B MYBBP1A EP400 TTC28 ARID4A CHD8 NUP214 CREBBP BAZ1A DZIP3 CRYBG3 UBASH3B L3MBTL3 EP300 PCM1 | 6.29e-05 | 1108 | 217 | 27 | int:HDAC1 |
| Interaction | H2BC21 interactions | ATRX TRIP12 ANAPC1 DYRK2 NAA16 EP400 ARID4A PCLO BAZ1B CHD8 SMG5 CREBBP USF3 BAZ1A DZIP3 SCAF11 L3MBTL3 LRIF1 EP300 ZNF292 | 6.80e-05 | 696 | 217 | 20 | int:H2BC21 |
| Interaction | KCNA3 interactions | DNAJB12 MYO9A NACA MPDZ DST CGN ALDH18A1 PLEKHA5 TTF2 MYBBP1A EDC3 TTC28 ARHGEF12 NUP214 CCDC88A LRP6 MACF1 RIMS1 CRYBG3 PATJ PLIN3 EPHA3 HDLBP | 6.98e-05 | 871 | 217 | 23 | int:KCNA3 |
| Interaction | CDC16 interactions | MYO9A CEP350 ANAPC1 PLEKHA5 CEP97 DDX11L8 CREBBP TAF3 ESPL1 EP300 TP53BP1 | 7.68e-05 | 246 | 217 | 11 | int:CDC16 |
| Interaction | ASF1A interactions | BDP1 NCOA6 NR2C2 ATRX LIN54 CHD6 NPAT EP400 CHD8 LRIF1 EP300 | 8.55e-05 | 249 | 217 | 11 | int:ASF1A |
| Interaction | YWHAB interactions | PDE3B MYO9A SPIRE1 TRIP12 CEP350 NEK4 USP31 DST SUN2 CGN ZBTB21 NHS PLEKHA5 CAMSAP2 ARAP2 CCSER1 EDC3 TTC28 RALGAPB MAP7 RFX7 CCDC88A MACF1 CGNL1 PCM1 | 9.98e-05 | 1014 | 217 | 25 | int:YWHAB |
| Interaction | OCLN interactions | PDE8A CLEC7A USP31 DST ZFYVE9 CGN NHS PLEKHA5 ARAP2 CCSER1 SDK2 ARHGEF12 CCDC88A MACF1 PCNX1 PATJ | 1.10e-04 | 500 | 217 | 16 | int:OCLN |
| Interaction | DENND1A interactions | 1.11e-04 | 101 | 217 | 7 | int:DENND1A | |
| Interaction | HERC2 interactions | SGO1 NEK4 TAF8 DST ZFYVE9 KIF15 C2CD6 TANK ARHGEF12 MAP7 CCDC88A GTF3C2 MACF1 PCM1 TP53BP1 HDLBP | 1.18e-04 | 503 | 217 | 16 | int:HERC2 |
| Interaction | CYTH4 interactions | 1.32e-04 | 46 | 217 | 5 | int:CYTH4 | |
| Interaction | PFN1 interactions | NR2C2 MYO9A CEP350 KIF15 PLEKHA5 CEP97 TTF2 STRN3 PCLO RALGAPB ARHGEF12 ELP1 MACF1 CRYBG3 LRIF1 TP53BP1 | 1.35e-04 | 509 | 217 | 16 | int:PFN1 |
| Interaction | ADAMTS13 interactions | 1.62e-04 | 26 | 217 | 4 | int:ADAMTS13 | |
| Interaction | TRIM36 interactions | 1.71e-04 | 144 | 217 | 8 | int:TRIM36 | |
| Interaction | PAX6 interactions | NCOA6 NR2C2 LIN54 KDM2B C2CD6 CHD6 EP400 CREBBP TAF3 GTF3C2 PATJ L3MBTL3 EP300 | 1.78e-04 | 366 | 217 | 13 | int:PAX6 |
| Interaction | FBXO38 interactions | 1.79e-04 | 145 | 217 | 8 | int:FBXO38 | |
| Interaction | KLF3 interactions | 1.90e-04 | 228 | 217 | 10 | int:KLF3 | |
| Interaction | CBX3 interactions | NR2C2 ATRX LIN54 SNRK SGO1 TRIP12 ZNF518A ZBTB21 KDM2B EP400 BAZ1B CHD8 MACF1 LRIF1 EP300 TP53BP1 ZNF292 HDLBP | 2.31e-04 | 646 | 217 | 18 | int:CBX3 |
| Interaction | CAMK2A interactions | TSR2 LIN54 MPDZ SNRK PLEKHA5 RALGAPB ELP1 NUP214 MAP7 RIMS1 PATJ | 2.31e-04 | 279 | 217 | 11 | int:CAMK2A |
| Interaction | H2AX interactions | NR2C2 ATR ATRX USP11 NACA TRIM29 NEK4 KDM2B NPAT ARID4A THUMPD1 BAZ1B CHD8 BAZ1A EP300 TP53BP1 C1orf174 | 2.48e-04 | 593 | 217 | 17 | int:H2AX |
| Interaction | TRPC6 interactions | 2.58e-04 | 82 | 217 | 6 | int:TRPC6 | |
| Interaction | DENND6A interactions | 2.75e-04 | 83 | 217 | 6 | int:DENND6A | |
| Interaction | IL17RA interactions | 2.82e-04 | 155 | 217 | 8 | int:IL17RA | |
| Cytoband | 16p12.3 | 2.20e-05 | 34 | 222 | 4 | 16p12.3 | |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 1.36e-05 | 7 | 134 | 3 | 135 | |
| GeneFamily | EF-hand domain containing|Plakins | 2.17e-05 | 8 | 134 | 3 | 939 | |
| GeneFamily | PDZ domain containing | 1.39e-04 | 152 | 134 | 7 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 1.91e-04 | 160 | 134 | 7 | 555 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.99e-04 | 18 | 134 | 3 | 91 | |
| GeneFamily | Sterile alpha motif domain containing | 4.97e-04 | 88 | 134 | 5 | 760 | |
| GeneFamily | Perilipins | 5.37e-04 | 5 | 134 | 2 | 678 | |
| GeneFamily | Phosphodiesterases | 7.19e-04 | 24 | 134 | 3 | 681 | |
| GeneFamily | Zinc fingers AN1-type|UPF1 like RNA helicases | 1.48e-03 | 8 | 134 | 2 | 63 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.66e-03 | 115 | 134 | 5 | 769 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.90e-03 | 9 | 134 | 2 | 1223 | |
| GeneFamily | UPF1 like RNA helicases | 2.87e-03 | 11 | 134 | 2 | 1169 | |
| GeneFamily | Immunoglobulin like domain containing | 3.18e-03 | 193 | 134 | 6 | 594 | |
| GeneFamily | Low density lipoprotein receptors | 4.03e-03 | 13 | 134 | 2 | 634 | |
| GeneFamily | PHD finger proteins | 4.51e-03 | 90 | 134 | 4 | 88 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 5.37e-03 | 15 | 134 | 2 | 26 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 6.89e-03 | 17 | 134 | 2 | 486 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 7.12e-03 | 53 | 134 | 3 | 532 | |
| GeneFamily | Ubiquitin specific peptidases | 8.29e-03 | 56 | 134 | 3 | 366 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SP3 PDE8A ATR ATRX TRIP12 F3 CEP350 NEK4 RGL1 DST ZFYVE9 DMD CAMSAP2 ARAP2 NPAT STRN3 TRIM2 TANK TTC28 ARID4A BAZ1B REV3L CREBBP AFAP1 GTF3C2 BAZ1A RBM6 MACF1 BICRAL CRYBG3 DAAM1 TP53BP1 ZNF292 | 3.17e-13 | 856 | 221 | 33 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | SMG1 CEP350 KIF15 VWA3B ARAP2 BAZ1B RFX7 CREBBP MACF1 ESPL1 NFAT5 EP300 PCM1 | 4.75e-09 | 180 | 221 | 13 | M8239 |
| Coexpression | GABRIELY_MIR21_TARGETS | ATRX MYO9A MPDZ DMD CEP97 WNK3 TRIM2 ARID4A ARHGEF12 REV3L RFX7 SLC5A3 SCAF11 NFAT5 ZNF292 | 2.72e-08 | 289 | 221 | 15 | M2196 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 SMG1 SP3 ATR ATRX SNRK TRIP12 ZBED5 CEP350 SUN2 ARAP2 DYRK2 NPAT TANK EP400 ARID4A RALGAPB AGGF1 ELP1 BAZ1B REV3L RFX7 CREBBP SLC5A3 CCDC88A BAZ1A DZIP3 MACF1 PCNX1 SCAF11 UBASH3B NFAT5 EP300 PCM1 ZNF292 | 3.87e-08 | 1492 | 221 | 35 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PDE8A ATR ATRX TRIP12 F3 CEP350 DST ZFYVE9 CAMSAP2 STRN3 TRIM2 REV3L CREBBP AFAP1 BAZ1A RBM6 ZNF292 | 5.12e-07 | 466 | 221 | 17 | M13522 |
| Coexpression | QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE | NCOA6 SP3 NACA IST1 SNRK TRIP12 SERPINA1 KDM2B TRMT5 THUMPD1 CREBBP NOMO1 SCAF11 | 1.44e-06 | 294 | 221 | 13 | M40873 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 ATRX LIN54 CGN NGEF KDM2B C2CD6 CAMSAP2 WNK3 DYRK2 CCSER1 CNTN4 TRIM2 SLC4A8 ARID4A PCLO ARHGEF12 REV3L RFX7 PTPRT SLC5A3 CCDC88A RIMS1 DAAM1 UBASH3B EPHA3 | 2.49e-06 | 1106 | 221 | 26 | M39071 |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | ATRX MPDZ NEK4 DYRK2 EP400 SLC5A3 SLC16A4 MACF1 DIXDC1 ZNF292 | 7.90e-06 | 199 | 221 | 10 | M8381 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | SP3 ATRX CEP350 DST DYRK2 NPAT BAZ1B REV3L CREBBP BAZ1A SCAF11 BICRAL | 1.01e-05 | 300 | 221 | 12 | M8702 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 1.97e-05 | 221 | 221 | 10 | M39222 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.97e-05 | 176 | 221 | 9 | M39223 | |
| Coexpression | BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP | 2.21e-05 | 137 | 221 | 8 | M34024 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP | 5.15e-05 | 199 | 221 | 9 | M6443 | |
| Coexpression | GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN | 5.15e-05 | 199 | 221 | 9 | M9236 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NKTCELL_DN | 5.35e-05 | 200 | 221 | 9 | M4825 | |
| Coexpression | GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN | 5.35e-05 | 200 | 221 | 9 | M4334 | |
| Coexpression | TRAVAGLINI_LUNG_CILIATED_CELL | MARCHF10 TTC16 USP11 MPDZ ODAD4 STOX1 TRIM29 NEK4 GPC3 ULK4 VWA3B DMD KIAA2012 DNAH9 CEP97 BICC1 PTPRT ADGB DZIP3 DIXDC1 PLIN3 PCM1 TP53BP1 | 5.54e-05 | 1093 | 221 | 23 | M41649 |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_708_5P_GENES | 5.74e-05 | 49 | 221 | 5 | MM17508 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 9.00e-05 | 86 | 221 | 6 | M39248 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | SMG1 CEP350 CAMSAP2 ARAP2 CREBBP USF3 CCDC88A MACF1 CRYBG3 UBASH3B | 9.08e-05 | 265 | 221 | 10 | M1684 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | SMG1 SP3 NACA NEK4 DST GPC3 STRN3 TRIM2 TANK TEK CREBBP SLC5A3 SLC16A4 PAM SCAF11 | 1.05e-04 | 568 | 221 | 15 | M4023 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | SMG1 CEP350 CAMSAP2 ARAP2 CREBBP USF3 CCDC88A MACF1 CRYBG3 UBASH3B | 1.12e-04 | 272 | 221 | 10 | MM1027 |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN | PDE3A PDE8A LRRC37A2 TRIM29 PLIN2 PARP6 C3 DMD COL6A1 TTC28 SLC5A3 AFAP1 PAM MACF1 EP300 ZNF292 | 1.34e-04 | 648 | 221 | 16 | M14371 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 ATR MYO9A ZCCHC2 CEP350 BMP7 KIF15 TRIM2 AGGF1 BAZ1B REV3L CCDC88A BAZ1A SCAF11 DAAM1 PCM1 | 1.54e-04 | 656 | 221 | 16 | M18979 |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP | 1.65e-04 | 96 | 221 | 6 | M5549 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BDP1 NCOA6 ATRX ZNF518A NEK4 KIF15 SLC4A8 ARID4A BAZ1B REV3L AIFM2 USF3 CCDC88A AFAP1 SLC16A4 BAZ1A PCM1 ZNF292 | 3.41e-09 | 311 | 216 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 NCOA6 PDE3B ATR ATRX ZGRF1 LIN54 SPIRE1 SGO1 BCLAF3 CEP350 THAP2 SERPINA1 KIF15 DMD WNK3 NAA16 CCSER1 SLC4A8 ARID4A BAZ1B REV3L ERI2 SLC5A3 AIFM2 CCDC88A BAZ1A DZIP3 MACF1 SCAF11 DIXDC1 LRIF1 PCM1 TP53BP1 ZNF292 C1orf174 | 1.65e-08 | 1257 | 216 | 36 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | PDE3A CEP350 USP31 BMP7 CAMSAP2 TTC28 BAZ1B NUP214 REV3L DIXDC1 NFAT5 EPHA3 | 4.23e-08 | 149 | 216 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 SP3 ATRX SGO1 ZNF518A DST ZFYVE9 KIF15 NAA16 TTF2 ARID4A BAZ1B RFX7 AIFM2 SLC16A4 BAZ1A DZIP3 RBM6 SCAF11 ZNF292 | 7.68e-08 | 469 | 216 | 20 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | BDP1 ATRX MPDZ SLC4A8 TTC28 ARID4A PCLO ARHGEF12 BAZ1B AIFM2 BAZ1A MACF1 SCAF11 | 8.98e-08 | 192 | 216 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | SMG1 PDE3A CEP350 USP31 RGL1 BMP7 ANAPC1 PLEKHA5 CAMSAP2 BAZ1B NUP214 REV3L DIXDC1 NFAT5 EPHA3 HDLBP | 1.39e-07 | 312 | 216 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BDP1 NCOA6 PDE3B ATR ATRX ZGRF1 LIN54 SPIRE1 SGO1 BCLAF3 CEP350 THAP2 SERPINA1 KIF15 DMD WNK3 NAA16 CCSER1 SLC4A8 ARID4A BAZ1B REV3L ERI2 SLC5A3 AIFM2 CCDC88A BAZ1A DZIP3 MACF1 SCAF11 DIXDC1 LRIF1 PCM1 TP53BP1 EPHA3 ZNF292 C1orf174 | 2.26e-07 | 1459 | 216 | 37 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | SMG1 CEP350 USP31 ANAPC1 PLEKHA5 CAMSAP2 TTC28 VEZT BAZ1B NUP214 REV3L EPHA3 HDLBP | 2.41e-07 | 209 | 216 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | PDE3A ATRX TRIP12 CEP350 NEK4 USP31 BMP7 PLEKHA5 CAMSAP2 VEZT BAZ1B NUP214 REV3L L3MBTL3 EPHA3 ZNF292 | 1.30e-06 | 369 | 216 | 16 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | SMG1 PDE3A ATRX CEP350 USP31 PLEKHA5 CAMSAP2 VEZT BAZ1B REV3L CREBBP DZIP3 DIXDC1 NFAT5 EPHA3 | 1.57e-06 | 330 | 216 | 15 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | BDP1 SMG1 ATRX TRIP12 CEP350 PLEKHA5 CAMSAP2 RALGAPB BAZ1B NUP214 REV3L DZIP3 DIXDC1 NFAT5 ZNF292 HDLBP | 1.60e-06 | 375 | 216 | 16 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 NCOA6 ATRX IST1 TTC28 ARID4A BAZ1B AIFM2 USF3 CCDC88A BAZ1A MACF1 SCAF11 EPHA3 | 1.83e-06 | 291 | 216 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | BDP1 NCOA6 ATRX ZNF518A NEK4 FREM2 KIF15 PLEKHM2 DMD CEP97 SLC4A8 ARID4A PCLO BAZ1B REV3L MAP7 AIFM2 USF3 CCDC88A AFAP1 SLC16A4 BAZ1A DAAM1 LRIF1 PCM1 EPHA3 ZNF292 | 3.07e-06 | 989 | 216 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | BDP1 NHS BAZ1B CREBBP AIFM2 TAF3 CCDC88A BAZ1A DZIP3 MACF1 PCM1 | 3.38e-06 | 186 | 216 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NCOA6 SP3 PDE3B PDE8A ATR ATRX LIN54 SGO1 ZNF518A BCLAF3 IGSF10 THAP2 BMP7 SERPINA1 TAF8 KIF15 NHS WNK3 NAA16 MPP1 ARID4A REV3L ERI2 TAF3 CCDC88A BAZ1A DZIP3 DIXDC1 LRIF1 PCM1 ZNF292 | 4.03e-06 | 1252 | 216 | 31 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 NCOA6 ATRX MYO9A LIN54 IST1 PLEKHA5 TANK SLC4A8 TTC28 ARID4A ARHGEF12 BAZ1B REV3L AIFM2 USF3 CCDC88A AFAP1 BAZ1A ZFYVE19 MACF1 SCAF11 EPHA3 | 5.05e-06 | 780 | 216 | 23 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 6.46e-06 | 69 | 216 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 ATRX TRO ZGRF1 TBC1D8B BCLAF3 ZFYVE9 DMD ARID4A ARHGEF12 BAZ1B ZFAND4 AIFM2 TAF3 SLC16A4 BAZ1A MACF1 PCM1 EPHA3 ZNF292 | 7.25e-06 | 629 | 216 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | SMG1 ATRX CEP350 BMP7 PLEKHA5 CAMSAP2 BICC1 TRIM2 VEZT BAZ1B NUP214 REV3L SLC5A3 NFAT5 HDLBP | 8.46e-06 | 379 | 216 | 15 | gudmap_developingKidney_e15.5_1000_k3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | BDP1 NCOA6 PDE3A MARCHF10 ATRX IST1 MPDZ PLEKHM2 CCSER1 SLC4A8 TTC28 ARID4A PCLO ARHGEF12 BAZ1B REV3L AIFM2 USF3 CCDC88A BAZ1A MACF1 SCAF11 DIXDC1 DAAM1 LRIF1 EPHA3 | 8.63e-06 | 985 | 216 | 26 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 CEP350 USP31 RGL1 BMP7 ANAPC1 PLEKHA5 CAMSAP2 TTC28 VEZT BAZ1B NUP214 REV3L EPHA3 HDLBP | 1.02e-05 | 385 | 216 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | SMG1 ATRX CEP350 BMP7 PLEKHA5 CAMSAP2 BAZ1B NUP214 REV3L BAZ1A MCM9 DIXDC1 NFAT5 HDLBP | 1.06e-05 | 339 | 216 | 14 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | BDP1 PDE3A ATRX MPDZ CCSER1 SLC4A8 TTC28 ARID4A PCLO ARHGEF12 BAZ1B REV3L AIFM2 BAZ1A MACF1 SCAF11 DIXDC1 | 1.25e-05 | 492 | 216 | 17 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 NCOA6 ATRX MYO9A LIN54 IST1 ZNF518A NEK4 KIF15 DMD SLC4A8 ARID4A PCLO BAZ1B AIFM2 CCDC88A AFAP1 SLC16A4 BAZ1A ZFYVE19 PCM1 EPHA3 ZNF292 | 1.40e-05 | 831 | 216 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | BDP1 SMG1 ATRX TRIP12 CEP350 CGN PLEKHA5 CAMSAP2 ARAP2 CCSER1 VEZT RALGAPB BAZ1B NUP214 REV3L MAP7 DZIP3 DIXDC1 PATJ NFAT5 ZNF292 HDLBP | 1.45e-05 | 774 | 216 | 22 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 CEP350 BMP7 PLEKHA5 CAMSAP2 STRN3 BAZ1B NUP214 REV3L GTF3C2 NFAT5 HDLBP | 1.59e-05 | 261 | 216 | 12 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | SPIRE1 PLEKHM2 NHS DMD BAZ1B AIFM2 CCDC88A BAZ1A MACF1 DAAM1 PCM1 EPHA3 | 2.31e-05 | 271 | 216 | 12 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | NR2C2 USP11 SPIRE1 TBC1D8B CEP350 DST PLEKHM2 CHD6 DMD TRIM2 SLC4A8 PCLO CHD8 AIFM2 BAZ1A PAM DAAM1 L3MBTL3 PCM1 EPHA3 | 2.64e-05 | 688 | 216 | 20 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BDP1 MARCHF10 ATRX TRO MPDZ BCLAF3 TRMT5 ARAP2 ARID4A PCLO ARHGEF12 BAZ1B SMG5 REV3L MAP7 ZFAND4 AIFM2 TAF3 BAZ1A MACF1 DIXDC1 LRIF1 PLIN3 PCM1 ZNF292 | 2.68e-05 | 989 | 216 | 25 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | NR2C2 PDE3B SPIRE1 TBC1D8B CEP350 DST KIF15 NHS CHD6 DMD ABTB2 SLC4A8 PCLO CHD8 ZFAND4 AIFM2 BAZ1A PAM EPHA3 | 4.26e-05 | 654 | 216 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 PDE3A PDE8A IGSF10 SUN2 NHS SHISAL2A ABTB2 BICC1 MPP1 COL6A1 SDK2 TTC28 BAZ1B CREBBP ZFAND4 TAF3 CCDC88A DZIP3 MACF1 DIXDC1 UBASH3B | 4.49e-05 | 834 | 216 | 22 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | SMG1 ATRX CEP350 NEK4 BMP7 DST PLEKHA5 CAMSAP2 BICC1 TRIM2 VEZT BAZ1B NUP214 REV3L MAP7 SLC5A3 PAM DIXDC1 PATJ NFAT5 HDLBP | 6.60e-05 | 795 | 216 | 21 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 PDE3B ATRX TRO ZGRF1 NEK4 ZFYVE9 NPAT ARID4A BAZ1B TAF3 SLC16A4 DZIP3 MACF1 PLIN3 PCM1 ZNF292 | 6.97e-05 | 564 | 216 | 17 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_200 | 7.31e-05 | 43 | 216 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_1000 | TRO TRIP12 NEK4 ANAPC1 ZBTB21 CNTN4 ARID4A ZFAND4 MCM9 LRP6 SCAF11 CGNL1 | 7.71e-05 | 307 | 216 | 12 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | PDE3A TRIM29 CEP350 USP31 BMP7 DST CAMSAP2 TTC28 BAZ1B NUP214 REV3L DIXDC1 NFAT5 EPHA3 | 7.80e-05 | 407 | 216 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | SMG1 PDE3A TRIM29 CEP350 USP31 RGL1 BMP7 DST ANAPC1 PLEKHA5 CAMSAP2 TTC28 BAZ1B NUP214 REV3L DIXDC1 PATJ NFAT5 L3MBTL3 EPHA3 HDLBP | 8.01e-05 | 806 | 216 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 PDE3B SPIRE1 SGO1 ZNF518A NEK4 KIF15 TTF2 PCLO MAP7 RFX7 AIFM2 BAZ1A RBM6 SCAF11 C1orf174 | 1.17e-04 | 532 | 216 | 16 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 ATRX TRO BCLAF3 ARID4A BAZ1B REV3L ZFAND4 TAF3 BAZ1A MACF1 DIXDC1 PCM1 ZNF292 | 1.46e-04 | 432 | 216 | 14 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.60e-04 | 192 | 216 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_top-relative-expression-ranked_1000 | SMG1 CNKSR1 F3 CEP350 BMP7 TMEM191B CGN PLEKHA5 CAMSAP2 ARAP2 STRN3 VEZT BAZ1B NUP214 REV3L MAP7 GTF3C2 PATJ NFAT5 HDLBP | 1.63e-04 | 786 | 216 | 20 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | PDE3A PDE8A ATRX IGSF10 SUN2 NHS SHISAL2A ABTB2 BICC1 COL6A1 SDK2 TTC28 BAZ1A MACF1 SCAF11 ZNF292 BAALC | 1.68e-04 | 607 | 216 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_200 | 2.01e-04 | 53 | 216 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 2.25e-04 | 201 | 216 | 9 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | SP3 PDE3A ATRX TRIM29 TRIP12 CEP350 NEK4 USP31 BMP7 DST PLEKHA5 CAMSAP2 ARAP2 VEZT BAZ1B NUP214 REV3L L3MBTL3 EPHA3 ZNF292 | 2.27e-04 | 806 | 216 | 20 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | SMG1 PDE3A CEP350 USP31 ANAPC1 PLEKHA5 BAZ1B NUP214 DZIP3 DIXDC1 CGNL1 L3MBTL3 HDLBP | 2.27e-04 | 397 | 216 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.43e-04 | 203 | 216 | 9 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | KIF15 NHS DMD SLC4A8 ARID4A PCLO CHD8 AIFM2 BAZ1A SCAF11 ZNF292 | 2.51e-04 | 298 | 216 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | ATRX CEP350 PLEKHA5 CAMSAP2 VEZT BAZ1B REV3L MAP7 SLC5A3 DIXDC1 PATJ NFAT5 HDLBP | 2.57e-04 | 402 | 216 | 13 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | SMG1 PDE3A ATRX CEP350 USP31 PLEKHA5 CAMSAP2 ARAP2 CCSER1 CNTN4 TRIM2 VEZT BAZ1B REV3L CREBBP MCM9 DZIP3 DIXDC1 NFAT5 EPHA3 | 2.75e-04 | 818 | 216 | 20 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#2_top-relative-expression-ranked_200 | 2.80e-04 | 88 | 216 | 6 | gudmap_developingKidney_e15.5_200_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | SMG1 PDE3B PDE8A ATR MYO9A ZGRF1 ZNF518A BCLAF3 USP31 SYCP2 ZFYVE9 ATF7IP2 TRMT5 WNK3 NAA16 NPAT ZFAND4 BAZ1A DZIP3 ESPL1 | 2.84e-04 | 820 | 216 | 20 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.01e-04 | 209 | 216 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | TRIM29 CEP350 USP31 FREM2 BMP7 SERPINA1 DST CAMSAP2 ABTB2 TRIM2 VEZT BAZ1B NUP214 REV3L ZFAND4 DIXDC1 RIMS1 NFAT5 L3MBTL3 | 3.44e-04 | 769 | 216 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | SMG1 CEP350 USP31 ANAPC1 PLEKHA5 CAMSAP2 TTC28 VEZT BAZ1B NUP214 REV3L EPHA3 HDLBP | 3.56e-04 | 416 | 216 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TSR2 SP3 PDE3B PDE8A ATR ATRX LIN54 SGO1 ZNF518A IGSF10 GPC3 KIF15 NHS NAA16 BAZ1B CCDC88A BAZ1A DZIP3 FKBPL MACF1 SCAF11 DIXDC1 LRIF1 PCM1 EPHA3 ZNF292 | 3.82e-04 | 1241 | 216 | 26 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SMG1 ATRX TRO ZGRF1 THAP2 ZFYVE9 WNK3 ARID4A PCLO ARHGEF12 BAZ1B TAF3 SLC16A4 MACF1 EP300 ZNF292 | 4.10e-04 | 595 | 216 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | BDP1 SPIRE1 IGSF10 PLEKHM2 NHS DMD SHISAL2A CCSER1 CNTN4 COL6A1 BAZ1B CREBBP AIFM2 TAF3 CCDC88A BAZ1A DZIP3 MACF1 DIXDC1 DAAM1 PCM1 EPHA3 | 4.29e-04 | 978 | 216 | 22 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.53e-04 | 63 | 216 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 5.00e-04 | 98 | 216 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | BMP7 ANAPC1 PLEKHA5 CAMSAP2 ARHGEF12 BAZ1B NUP214 REV3L HDLBP | 5.32e-04 | 226 | 216 | 9 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | BDP1 PLEKHM2 NHS BAZ1B CREBBP AIFM2 TAF3 CCDC88A BAZ1A DZIP3 MACF1 DIXDC1 DAAM1 PCM1 | 5.42e-04 | 492 | 216 | 14 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | SMG1 ATRX CEP350 BMP7 ATF7IP2 PLEKHA5 CAMSAP2 VEZT BAZ1B NUP214 REV3L MAP7 BAZ1A MCM9 DIXDC1 PATJ NFAT5 C1orf174 HDLBP | 5.66e-04 | 801 | 216 | 19 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | PDE3B ATR MYO9A ZGRF1 ZNF518A BCLAF3 SYCP2 ATF7IP2 WNK3 ZFAND4 DZIP3 ESPL1 | 6.12e-04 | 385 | 216 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 6.22e-04 | 231 | 216 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | BDP1 PDE3A PDE8A ATRX IGSF10 SUN2 SHISAL2A ABTB2 BICC1 MPP1 COL6A1 SDK2 TTC28 REV3L CCDC88A MACF1 DIXDC1 BAALC | 6.30e-04 | 744 | 216 | 18 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 6.48e-04 | 39 | 216 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.78e-04 | 187 | 216 | 8 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | ATRX TRO SGO1 TRIP12 NEK4 RGL1 ANAPC1 ZBTB21 CNTN4 TANK ARID4A VEZT ZFAND4 SLC16A4 MCM9 LRP6 SCAF11 CGNL1 NFAT5 | 7.39e-04 | 819 | 216 | 19 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.51e-04 | 146 | 216 | 7 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_500 | 7.57e-04 | 106 | 216 | 6 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 8.61e-04 | 194 | 216 | 8 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_top-relative-expression-ranked_1000 | ATRX CLEC7A NEK4 USP31 BMP7 SERPINA1 ANAPC1 ABTB2 CNTN4 ARHGEF12 TEK ZFAND4 PTPRT BAZ1A MCM9 IRAG2 CGNL1 NFAT5 EPHA3 | 9.41e-04 | 836 | 216 | 19 | gudmap_developingKidney_e15.5_Podocyte cells_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_200 | 1.07e-03 | 155 | 216 | 7 | gudmap_developingKidney_e15.5_anlage of loop of Henle_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.07e-03 | 301 | 216 | 10 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3 | SPIRE1 CEP350 ZFYVE9 PVR ATF7IP2 TANK SLC4A8 ARHGEF12 CCDC88A PAM DAAM1 NFAT5 | 1.08e-03 | 411 | 216 | 12 | GSM538271_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.08e-03 | 201 | 216 | 8 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 1.11e-03 | 156 | 216 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SMG1 NR2C2 SP3 ATRX RGL1 BICC1 COL6A1 CHD8 CREBBP SLC5A3 SCAF11 EPHA3 | 1.12e-03 | 413 | 216 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.19e-03 | 204 | 216 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 1.20e-03 | 78 | 216 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_200 | 1.21e-03 | 21 | 216 | 3 | gudmap_developingGonad_e14.5_ epididymis_200_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_500 | 1.21e-03 | 116 | 216 | 6 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 1.43e-03 | 163 | 216 | 7 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PDE3A ATRX MYO9A CEP350 IGSF10 DMD CCDC88A PAM MACF1 SCAF11 PCM1 HDLBP | 9.55e-11 | 176 | 222 | 12 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | SMG1 SP3 ATRX CEP350 NPAT ARID4A ARHGEF12 THUMPD1 CREBBP SCAF11 NFAT5 EP300 | 1.81e-10 | 186 | 222 | 12 | 03db813598b67b1e08f759758a1c2023396921fa |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | BDP1 SMG1 ATRX ZCCHC2 TRIP12 CEP350 ARAP2 MACF1 SCAF11 PCM1 MX1 ZNF292 | 4.18e-10 | 200 | 222 | 12 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | BDP1 GPC3 PLEKHA5 CHD6 TTC28 LRP6 SCAF11 DAAM1 NFAT5 PCM1 ZNF292 | 3.69e-09 | 192 | 222 | 11 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO9A NHS PLEKHA5 ABTB2 BICC1 CCSER1 TRIM2 PCLO MAP7 CGNL1 PATJ | 4.34e-09 | 195 | 222 | 11 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.87e-08 | 188 | 222 | 10 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | MARCHF10 ODAD4 ULK4 VWA3B KIAA2012 DNAH9 BICC1 PTPRT ADGB DZIP3 | 4.96e-08 | 193 | 222 | 10 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 4.96e-08 | 193 | 222 | 10 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-08 | 194 | 222 | 10 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.61e-08 | 199 | 222 | 10 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.61e-08 | 199 | 222 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-07 | 162 | 222 | 9 | 2f19539c455d1e5d514725845234c7547020e6ad | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-07 | 174 | 222 | 9 | a79ebb01a5849c314e02594a9c95009dbb03cb8c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MARCHF10 ODAD4 STOX1 RSPH10B2 VWA3B KIAA2012 DNAH9 PTPRT ADGB | 3.32e-07 | 181 | 222 | 9 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.48e-07 | 182 | 222 | 9 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.48e-07 | 182 | 222 | 9 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 3.64e-07 | 183 | 222 | 9 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-07 | 184 | 222 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-07 | 185 | 222 | 9 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | MARCHF10 ODAD4 STOX1 RSPH10B2 VWA3B KIAA2012 DNAH9 PTPRT ADGB | 3.99e-07 | 185 | 222 | 9 | 30f4980dee6cd5959655f8d74049f3bfb5312611 |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-07 | 185 | 222 | 9 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.78e-07 | 189 | 222 | 9 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.22e-07 | 191 | 222 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.45e-07 | 192 | 222 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.45e-07 | 192 | 222 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.70e-07 | 193 | 222 | 9 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.70e-07 | 193 | 222 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 5.70e-07 | 193 | 222 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.70e-07 | 193 | 222 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-07 | 194 | 222 | 9 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-07 | 194 | 222 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.95e-07 | 194 | 222 | 9 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.21e-07 | 195 | 222 | 9 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-07 | 196 | 222 | 9 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-07 | 196 | 222 | 9 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.48e-07 | 196 | 222 | 9 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.76e-07 | 197 | 222 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.76e-07 | 197 | 222 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.36e-07 | 199 | 222 | 9 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.36e-07 | 199 | 222 | 9 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.36e-07 | 199 | 222 | 9 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.36e-07 | 199 | 222 | 9 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.67e-07 | 200 | 222 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 9.39e-07 | 151 | 222 | 8 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Ciliated_cells-A-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-06 | 159 | 222 | 8 | 0c65ae6140abd48c79b04758a6217709ddd15385 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-06 | 164 | 222 | 8 | d5bb57c321f2973836efc8990449494cc1fb87c7 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.75e-06 | 164 | 222 | 8 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-06 | 169 | 222 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-06 | 173 | 222 | 8 | 090dc3c5bd2652a65c2490fc889da858c3af368f | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.72e-06 | 174 | 222 | 8 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | Ciliated_cells-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.96e-06 | 176 | 222 | 8 | 1c364155f46b9a7c995bdc2cc2333c437cd90f5b | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.64e-06 | 181 | 222 | 8 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.79e-06 | 182 | 222 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-06 | 183 | 222 | 8 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.11e-06 | 184 | 222 | 8 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.45e-06 | 186 | 222 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-06 | 187 | 222 | 8 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.63e-06 | 187 | 222 | 8 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.63e-06 | 187 | 222 | 8 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.63e-06 | 187 | 222 | 8 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | (7)_Epithelial-F_(Ciliated)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.82e-06 | 188 | 222 | 8 | 9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.82e-06 | 188 | 222 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.01e-06 | 189 | 222 | 8 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.01e-06 | 189 | 222 | 8 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.21e-06 | 190 | 222 | 8 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-06 | 190 | 222 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.21e-06 | 190 | 222 | 8 | 17829f4de31b3d9e4d71ba4817d18842aa699773 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.21e-06 | 190 | 222 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.21e-06 | 190 | 222 | 8 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.21e-06 | 190 | 222 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.41e-06 | 191 | 222 | 8 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.41e-06 | 191 | 222 | 8 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 5.62e-06 | 192 | 222 | 8 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-06 | 192 | 222 | 8 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-06 | 192 | 222 | 8 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-06 | 192 | 222 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.62e-06 | 192 | 222 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-06 | 192 | 222 | 8 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-06 | 192 | 222 | 8 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.62e-06 | 192 | 222 | 8 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.84e-06 | 193 | 222 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-06 | 193 | 222 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-06 | 193 | 222 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.07e-06 | 194 | 222 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-06 | 194 | 222 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.07e-06 | 194 | 222 | 8 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.30e-06 | 195 | 222 | 8 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 195 | 222 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 6.30e-06 | 195 | 222 | 8 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-06 | 195 | 222 | 8 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c3-LAMP3|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.37e-06 | 139 | 222 | 7 | bb2b020dda32ddc60ec9952de5b01acee60b5b59 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 6.54e-06 | 196 | 222 | 8 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-06 | 197 | 222 | 8 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.79e-06 | 197 | 222 | 8 | 8c24ffcd417da42fa9bcbe6bd0325360e537303f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.79e-06 | 197 | 222 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.79e-06 | 197 | 222 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.79e-06 | 197 | 222 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.79e-06 | 197 | 222 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.79e-06 | 197 | 222 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 6.79e-06 | 197 | 222 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.33e-06 | 49 | 135 | 7 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.54e-05 | 50 | 135 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Clorgyline | BDP1 ATRX TBC1D8B CEP350 THAP2 DST ARAP2 NPAT ARID4A REV3L SCAF11 PCM1 ZNF292 | 9.13e-09 | 168 | 218 | 13 | ctd:D003010 |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | PDE8A CEP350 NEK4 KIF15 PLEKHA5 CAMSAP2 REV3L MAP7 CREBBP BAZ1A SCAF11 DAAM1 | 2.13e-07 | 183 | 218 | 12 | 7498_DN |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; PC3; HT_HG-U133A | MPDZ SERPINA1 ABTB2 TANK RALGAPB ARHGEF12 BAZ1B MAP7 MCM9 DZIP3 PCNX1 PCM1 | 4.22e-07 | 195 | 218 | 12 | 7400_DN |
| Drug | Succimer | SMG1 NR2C2 ATRX CLEC7A ZCCHC2 TRIM29 TBC1D8B F3 ZNF518A THAP2 SERPINA1 ANAPC1 C3 ABTB2 STRN3 VTN TRIM2 TANK REV3L RFX7 CREBBP SLC5A3 CCDC88A GTF3C2 SLC16A4 BAZ1A DZIP3 DAAM1 NFAT5 PCM1 ZNF292 | 1.44e-06 | 1264 | 218 | 31 | ctd:D004113 |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | DNAJB12 MPDZ ZCCHC2 ZBED5 CEP350 BMP7 PLEKHA5 NPAT SLC5A3 MCM9 BICRAL | 1.54e-06 | 182 | 218 | 11 | 3630_DN |
| Drug | Magnetite Nanoparticles | SMG1 NR2C2 ATRX CLEC7A ZCCHC2 TRIM29 TBC1D8B F3 ZNF518A THAP2 SERPINA1 ANAPC1 C3 ABTB2 STRN3 VTN TRIM2 TANK REV3L RFX7 CREBBP SLC5A3 CCDC88A GTF3C2 SLC16A4 BAZ1A DZIP3 DAAM1 NFAT5 PCM1 ZNF292 | 3.01e-06 | 1310 | 218 | 31 | ctd:D058185 |
| Drug | Suxibuzone [27470-51-5]; Up 200; 9.2uM; HL60; HT_HG-U133A | ATRX SYCP2 ZFYVE9 PVR TRIM2 REG1A ADGB CCDC88A DZIP3 LRP5 PCNX1 | 3.85e-06 | 200 | 218 | 11 | 2503_UP |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | DNAJB12 NCOA6 ZBED5 KIF15 REV3L CREBBP GTF3C2 BAZ1A MCM9 EP300 | 5.90e-06 | 170 | 218 | 10 | 1050_DN |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | ZBED5 CEP350 CAMSAP2 DYRK2 NAA16 TANK REV3L DAAM1 USPL1 ZNF292 | 1.24e-05 | 185 | 218 | 10 | 1114_DN |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | PDE3B ZCCHC2 PLEKHM2 CAMSAP2 ARAP2 CHD8 SLC5A3 BAZ1A LRP6 ESPL1 | 1.36e-05 | 187 | 218 | 10 | 4989_DN |
| Drug | Nocodazole [31430-18-9]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.79e-05 | 193 | 218 | 10 | 2076_DN | |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.87e-05 | 194 | 218 | 10 | 4470_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | DNAJB12 MYO9A MPDZ SERPINA1 ABTB2 TRIM2 RALGAPB LRP5 PCNX1 PCM1 | 1.96e-05 | 195 | 218 | 10 | 5004_DN |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A | DNAJB12 EVPL SYCP2 CEP97 TRIM2 ARHGEF12 DZIP3 BICRAL PATJ PCM1 | 1.96e-05 | 195 | 218 | 10 | 5329_DN |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | AP1G2 CAMSAP2 COL6A1 TRIM2 BAZ1B SMG5 LRP6 PCNX1 PCM1 ZNF292 | 2.05e-05 | 196 | 218 | 10 | 5833_DN |
| Drug | Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.05e-05 | 196 | 218 | 10 | 5521_DN | |
| Drug | Ethosuximide [77-67-8]; Down 200; 28.4uM; MCF7; HT_HG-U133A | 2.05e-05 | 196 | 218 | 10 | 2280_DN | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | ATRX SERPINA1 ZFYVE9 COL6A1 TRIM2 POM121L2 MAP7 PATJ NFAT5 PCM1 | 2.14e-05 | 197 | 218 | 10 | 1641_UP |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; MCF7; HT_HG-U133A | 2.23e-05 | 198 | 218 | 10 | 5422_UP | |
| Drug | Danazol [17230-88-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.23e-05 | 198 | 218 | 10 | 1538_DN | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; HL60; HG-U133A | SP3 PDE3B CLEC7A ARID4A RALGAPB NUP214 MACF1 BICRAL LRIF1 ZNF292 | 2.23e-05 | 198 | 218 | 10 | 1553_UP |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.23e-05 | 198 | 218 | 10 | 1070_DN | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.23e-05 | 198 | 218 | 10 | 6486_DN | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; PC3; HT_HG-U133A | TBC1D8B ABTB2 SLC4A8 RALGAPB CCDC88A AFAP1 PCNX1 BICRAL MX1 CPNE7 | 2.23e-05 | 198 | 218 | 10 | 4621_DN |
| Drug | Thimerosal | BDP1 NR2C2 ATRX MYO9A FRMD7 LRRC37A2 TBC1D8B CEP350 SYCP2 DST SUN2 PLEKHA5 NAA16 NPAT CCSER1 EP400 PCLO ARHGEF12 RFX7 SLC5A3 LRP6 PCNX1 RIMS1 NFAT5 PCM1 TP53BP1 C1orf174 | 3.32e-05 | 1199 | 218 | 27 | ctd:D013849 |
| Drug | 1,2-diaminocyclohexane | 3.51e-05 | 20 | 218 | 4 | CID000004610 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.57e-05 | 173 | 218 | 9 | 4665_DN | |
| Drug | Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 4.78e-05 | 174 | 218 | 9 | 1276_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 6.22e-05 | 180 | 218 | 9 | 4541_DN | |
| Drug | Palatinose hydrate | 6.28e-05 | 23 | 218 | 4 | CID000093971 | |
| Drug | 3,9-dimethyladenine | 6.28e-05 | 23 | 218 | 4 | CID000447936 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | DNAJB12 ZCCHC2 ZBED5 CEP350 CAMSAP2 STRN3 REV3L CREBBP BAZ1A | 6.78e-05 | 182 | 218 | 9 | 3887_DN |
| Drug | Phe-gly | 7.17e-05 | 73 | 218 | 6 | CID000098207 | |
| Drug | Rolitetracycline [751-97-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 7.69e-05 | 185 | 218 | 9 | 3369_DN | |
| Drug | C3 P | 8.83e-05 | 25 | 218 | 4 | CID000066535 | |
| Drug | propionyl chloride | 9.13e-05 | 2 | 218 | 2 | CID000062324 | |
| Drug | Inocor (TN) | 9.13e-05 | 2 | 218 | 2 | CID000656683 | |
| Drug | RS-1893 | 9.13e-05 | 2 | 218 | 2 | CID000128386 | |
| Drug | diphenyl phosphoroisothiocyanatidate | 9.13e-05 | 2 | 218 | 2 | CID000079397 | |
| Drug | proline thiohydantoin | 9.13e-05 | 2 | 218 | 2 | CID005363437 | |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.81e-05 | 191 | 218 | 9 | 6236_UP | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.02e-04 | 192 | 218 | 9 | 6254_DN | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A | 1.02e-04 | 192 | 218 | 9 | 6659_DN | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.06e-04 | 193 | 218 | 9 | 1480_UP | |
| Drug | Quercetine dihydrate [6151-25-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 193 | 218 | 9 | 4846_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 1.06e-04 | 193 | 218 | 9 | 2833_DN | |
| Drug | forskolin; Up 200; 50uM; HL60; HG-U133A | 1.06e-04 | 193 | 218 | 9 | 783_UP | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 194 | 218 | 9 | 2284_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.10e-04 | 194 | 218 | 9 | 3363_UP | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; HL60; HG-U133A | 1.19e-04 | 196 | 218 | 9 | 1597_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 2090_DN | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; HL60; HG-U133A | 1.19e-04 | 196 | 218 | 9 | 1399_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.19e-04 | 196 | 218 | 9 | 1497_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 1503_UP | |
| Drug | Clemastine fumarate [14976-57-9]; Down 200; 8.6uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 2412_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; HL60; HG-U133A | 1.24e-04 | 197 | 218 | 9 | 1363_UP | |
| Drug | Suprofen [40828-46-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 3005_DN | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 6257_DN | |
| Drug | Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 5840_UP | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 6949_DN | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.24e-04 | 197 | 218 | 9 | 4266_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; HL60; HG-U133A | 1.24e-04 | 197 | 218 | 9 | 1997_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 4804_UP | |
| Drug | monastrol; Up 200; 100uM; PC3; HG-U133A | 1.29e-04 | 198 | 218 | 9 | 668_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 6777_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; HL60; HG-U133A | 1.29e-04 | 198 | 218 | 9 | 1566_DN | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 5526_DN | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 6270_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 198 | 218 | 9 | 4956_UP | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.34e-04 | 199 | 218 | 9 | 4352_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; PC3; HT_HG-U133A | 1.34e-04 | 199 | 218 | 9 | 6285_UP | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.34e-04 | 199 | 218 | 9 | 7233_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.34e-04 | 199 | 218 | 9 | 2760_DN | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.39e-04 | 200 | 218 | 9 | 3008_DN | |
| Drug | testosterone enanthate | SMG1 PDE3A ATRX MYO9A MPDZ USP31 CAMSAP2 COL6A1 STRN3 AGGF1 CHD8 BAZ1A MACF1 SCAF11 NFAT5 MX1 | 1.44e-04 | 575 | 218 | 16 | ctd:C004648 |
| Drug | LD-CTA | 2.38e-04 | 32 | 218 | 4 | CID000065018 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.41e-04 | 170 | 218 | 8 | 1631_UP | |
| Drug | dyphylline | 2.69e-04 | 33 | 218 | 4 | CID000003182 | |
| Drug | SureCN4406168 | 2.72e-04 | 3 | 218 | 2 | CID011502028 | |
| Drug | SureCN4395097 | 2.72e-04 | 3 | 218 | 2 | CID011610011 | |
| Drug | SureCN4401117 | 2.72e-04 | 3 | 218 | 2 | CID011718172 | |
| Drug | SureCN4402206 | 2.72e-04 | 3 | 218 | 2 | CID011516917 | |
| Drug | WIN 62582 | 2.72e-04 | 3 | 218 | 2 | CID005487388 | |
| Drug | Food Green 3 | 2.72e-04 | 3 | 218 | 2 | CID000016887 | |
| Drug | colistin sulfate | 2.72e-04 | 3 | 218 | 2 | CID000073090 | |
| Drug | I-23 | 2.72e-04 | 3 | 218 | 2 | CID005318396 | |
| Drug | SureCN4397066 | 2.72e-04 | 3 | 218 | 2 | CID011538627 | |
| Drug | SureCN4401121 | 2.72e-04 | 3 | 218 | 2 | CID011611819 | |
| Drug | SureCN4404748 | 2.72e-04 | 3 | 218 | 2 | CID011502895 | |
| Drug | SureCN4411688 | 2.72e-04 | 3 | 218 | 2 | CID011523192 | |
| Drug | SureCN4405038 | 2.72e-04 | 3 | 218 | 2 | CID011546172 | |
| Drug | SureCN4405912 | 2.72e-04 | 3 | 218 | 2 | CID011682920 | |
| Drug | pelrinone | 2.72e-04 | 3 | 218 | 2 | CID000055919 | |
| Drug | 4-ADPV | 2.72e-04 | 3 | 218 | 2 | CID000130773 | |
| Drug | AC1MHUPJ | 2.72e-04 | 3 | 218 | 2 | CID003011739 | |
| Drug | SureCN4398032 | 2.72e-04 | 3 | 218 | 2 | CID011532088 | |
| Drug | o-xylylene | 2.72e-04 | 3 | 218 | 2 | CID000141735 | |
| Drug | SureCN4406373 | 2.72e-04 | 3 | 218 | 2 | CID011711104 | |
| Drug | SureCN4394894 | 2.72e-04 | 3 | 218 | 2 | CID011711103 | |
| Drug | SureCN5995113 | 2.72e-04 | 3 | 218 | 2 | CID011640499 | |
| Disease | pursuit maintenance gain measurement | 3.24e-05 | 123 | 213 | 7 | EFO_0008433 | |
| Disease | Leukemia, Myelocytic, Acute | 3.94e-05 | 173 | 213 | 8 | C0023467 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 5.19e-05 | 2 | 213 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.19e-05 | 2 | 213 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi Syndrome | 5.19e-05 | 2 | 213 | 2 | C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 5.19e-05 | 2 | 213 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 5.19e-05 | 2 | 213 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 5.19e-05 | 2 | 213 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome | 5.19e-05 | 2 | 213 | 2 | cv:C0035934 | |
| Disease | level of nodal modulator 1 in blood serum | 5.19e-05 | 2 | 213 | 2 | OBA_2044990 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 5.19e-05 | 2 | 213 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | NCOA6 LRRC37A2 TRIM29 F3 RGL1 LRRC37A NHS DMD DNAH9 DPAGT1 TANK ELP1 NUP214 TEK FKBPL MACF1 L3MBTL3 EP300 TP53BP1 HDLBP | 1.11e-04 | 1074 | 213 | 20 | C0006142 |
| Disease | nucleosome assembly protein 1-like 2 measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0801857 | |
| Disease | janus kinase and microtubule-interacting protein 3 measurement | 1.55e-04 | 3 | 213 | 2 | EFO_0801738 | |
| Disease | Manic Disorder | 1.65e-04 | 71 | 213 | 5 | C0024713 | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 1.78e-04 | 39 | 213 | 4 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | Carcinoma, Transitional Cell | 2.17e-04 | 41 | 213 | 4 | C0007138 | |
| Disease | red blood cell density measurement | SP3 ATR MYO9A LIN54 F3 DST PNPLA1 ULK4 EP400 SMG5 RFX7 ABCC6 TAF3 BAZ1A CGNL1 UBASH3B L3MBTL3 | 2.40e-04 | 880 | 213 | 17 | EFO_0007978 |
| Disease | Manic | 2.57e-04 | 78 | 213 | 5 | C0338831 | |
| Disease | triacylglycerol 56:6 measurement | 2.61e-04 | 43 | 213 | 4 | EFO_0010433 | |
| Disease | Depression, Bipolar | 2.73e-04 | 79 | 213 | 5 | C0005587 | |
| Disease | acute pancreatitis (is_marker_for) | 3.08e-04 | 4 | 213 | 2 | DOID:2913 (is_marker_for) | |
| Disease | zinc finger protein 175 measurement | 3.08e-04 | 4 | 213 | 2 | EFO_0802225 | |
| Disease | Malignant neoplasm of stomach | 3.54e-04 | 300 | 213 | 9 | C0024623 | |
| Disease | thalamus volume | 3.84e-04 | 85 | 213 | 5 | EFO_0006935 | |
| Disease | DnaJ homolog subfamily B member 9 measurement | 5.11e-04 | 5 | 213 | 2 | EFO_0801540 | |
| Disease | synaptosomal-associated protein 25 measurement | 5.11e-04 | 5 | 213 | 2 | EFO_0021858 | |
| Disease | acute kidney tubular necrosis (biomarker_via_orthology) | 5.11e-04 | 5 | 213 | 2 | DOID:12556 (biomarker_via_orthology) | |
| Disease | triacylglycerol 54:8 measurement | 5.90e-04 | 23 | 213 | 3 | EFO_0010426 | |
| Disease | glucagon measurement, glucose tolerance test | 7.63e-04 | 6 | 213 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | oleoyl-oleoyl-glycerol (18:1/18:1) [1] measurement | 7.63e-04 | 6 | 213 | 2 | EFO_0800497 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 8.53e-04 | 152 | 213 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | HVA measurement | 8.53e-04 | 26 | 213 | 3 | EFO_0005131 | |
| Disease | serum gamma-glutamyl transferase measurement | SP3 ATRX MYO9A SERPINA1 KDM2B C3 BICC1 ARAP2 SLC4A8 BAZ1B CGNL1 UBASH3B L3MBTL3 TP53BP1 ZNF292 HDLBP | 1.05e-03 | 914 | 213 | 16 | EFO_0004532 |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.06e-03 | 7 | 213 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.20e-03 | 222 | 213 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | C-reactive protein measurement | NCOA6 SP3 ZCCHC2 TRIP12 SERPINA1 ZPR1 PVR KDM2B KIAA2012 BAZ1B GTF3C2 MACF1 SCAF11 PATJ NFAT5 L3MBTL3 TP53BP1 EPHA3 HDLBP | 1.26e-03 | 1206 | 213 | 19 | EFO_0004458 |
| Disease | intraocular pressure measurement | TMCO5A ANAPC1 FAM186A BICC1 TTF2 COL6A1 PCLO ARHGEF12 AFAP1 FKBPL HDLBP | 1.26e-03 | 509 | 213 | 11 | EFO_0004695 |
| Disease | apolipoprotein A 1 measurement | PDE3A PDE3B LIN54 F3 BMP7 ZPR1 CGN CCSER1 VTN TRIM2 RBM6 MACF1 UBASH3B TP53BP1 HDLBP | 1.35e-03 | 848 | 213 | 15 | EFO_0004614 |
| Disease | Muscular Dystrophy | 1.41e-03 | 8 | 213 | 2 | C0026850 | |
| Disease | triacylglycerol 51:2 measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0021483 | |
| Disease | level of Triacylglycerol (49:2) in blood serum | 1.41e-03 | 8 | 213 | 2 | OBA_2045162 | |
| Disease | cytidine measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0800645 | |
| Disease | hepatitis A virus cellular receptor 2 measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0008151 | |
| Disease | calcium/calmodulin-dependent protein kinase type 1D measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0008063 | |
| Disease | PH and SEC7 domain-containing protein 1 measurement | 1.41e-03 | 8 | 213 | 2 | EFO_0803302 | |
| Disease | Stomach Neoplasms | 1.49e-03 | 297 | 213 | 8 | C0038356 | |
| Disease | serum IgG glycosylation measurement | 1.56e-03 | 523 | 213 | 11 | EFO_0005193 | |
| Disease | Large cell carcinoma of lung | 1.58e-03 | 32 | 213 | 3 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 1.58e-03 | 32 | 213 | 3 | C0149782 | |
| Disease | glycoprotein measurement | 1.75e-03 | 119 | 213 | 5 | EFO_0004555 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 1.81e-03 | 9 | 213 | 2 | EFO_0010613 | |
| Disease | Situs ambiguous | 1.81e-03 | 9 | 213 | 2 | C1167664 | |
| Disease | interleukin 25 measurement | 1.81e-03 | 9 | 213 | 2 | EFO_0008182 | |
| Disease | interleukin-36 alpha measurement | 1.81e-03 | 9 | 213 | 2 | EFO_0021851 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 1.84e-03 | 307 | 213 | 8 | EFO_0004612, EFO_0020946 | |
| Disease | triacylglycerol 58:8 measurement | 2.05e-03 | 35 | 213 | 3 | EFO_0010442 | |
| Disease | Acute Myeloid Leukemia, M1 | 2.18e-03 | 125 | 213 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 2.18e-03 | 125 | 213 | 5 | C1879321 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 2.25e-03 | 10 | 213 | 2 | C2931788 | |
| Disease | postburn hypertrophic scarring severity measurement | 2.25e-03 | 10 | 213 | 2 | EFO_0007747 | |
| Disease | OCIA domain-containing protein 1 measurement | 2.25e-03 | 10 | 213 | 2 | EFO_0008252 | |
| Disease | vitamin D deficiency | 2.40e-03 | 37 | 213 | 3 | EFO_0003762 | |
| Disease | Bipolar Disorder | ZCCHC2 ITIH4 NEK4 SERPINA1 ULK4 CNTN4 PCLO SLC5A3 DIXDC1 RIMS1 | 2.59e-03 | 477 | 213 | 10 | C0005586 |
| Disease | autism spectrum disorder, schizophrenia | 2.71e-03 | 327 | 213 | 8 | EFO_0003756, MONDO_0005090 | |
| Disease | response to ondansetron, QT interval | 2.73e-03 | 11 | 213 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | Situs Inversus | 2.73e-03 | 11 | 213 | 2 | C0037221 | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [1] measurement | 2.73e-03 | 11 | 213 | 2 | EFO_0800332 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.18e-03 | 264 | 213 | 7 | EFO_0008317, EFO_0020944 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 3.26e-03 | 12 | 213 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | ADHD symptom measurement | 3.26e-03 | 12 | 213 | 2 | EFO_0007860 | |
| Disease | polychlorinated biphenyls measurement, gestational serum measurement | 3.26e-03 | 12 | 213 | 2 | EFO_0007042, EFO_0007964 | |
| Disease | liver disease (is_implicated_in) | 3.26e-03 | 12 | 213 | 2 | DOID:409 (is_implicated_in) | |
| Disease | persulfide dioxygenase ETHE1, mitochondrial measurement | 3.26e-03 | 12 | 213 | 2 | EFO_0008258 | |
| Disease | complex trait | 3.67e-03 | 271 | 213 | 7 | EFO_0010578 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 3.84e-03 | 13 | 213 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | ximenoylcarnitine (C26:1) measurement | 3.84e-03 | 13 | 213 | 2 | EFO_0800543 | |
| Disease | tRNA (guanine-N(7)-)-methyltransferase measurement | 3.84e-03 | 13 | 213 | 2 | EFO_0802162 | |
| Disease | Anxiety Disorders | 3.95e-03 | 44 | 213 | 3 | C0003469 | |
| Disease | Anxiety States, Neurotic | 3.95e-03 | 44 | 213 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 3.95e-03 | 44 | 213 | 3 | C1279420 | |
| Disease | obsolete_red blood cell distribution width | TSR2 SP3 ATR LIN54 LRRC37A2 ZCCHC2 F3 PLIN2 ZPR1 KDM2B WNK3 EP400 TTC28 SMG5 FREM3 ZFAND4 RBM6 LRP5 EP300 | 4.27e-03 | 1347 | 213 | 19 | EFO_0005192 |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 4.46e-03 | 14 | 213 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | early cardiac repolarization measurement | 4.46e-03 | 14 | 213 | 2 | EFO_0004885 | |
| Disease | osteoprotegerin measurement | 4.46e-03 | 14 | 213 | 2 | EFO_0005918 | |
| Disease | sickle cell anemia (is_marker_for) | 4.46e-03 | 14 | 213 | 2 | DOID:10923 (is_marker_for) | |
| Disease | obesity (implicated_via_orthology) | 4.85e-03 | 215 | 213 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | TMCO5A PDE8A F3 PLIN2 NEK4 SERPINA1 ANO2 STRN3 ARHGEF12 REV3L CCDC88A AFAP1 BAZ1A MACF1 L3MBTL3 EPHA3 | 4.92e-03 | 1069 | 213 | 16 | EFO_0004346 |
| Disease | Situs ambiguus | 5.12e-03 | 15 | 213 | 2 | C0266642 | |
| Disease | response to peritoneal dialysis, peritoneal solute transfer rate | 5.12e-03 | 15 | 213 | 2 | EFO_0600089, EFO_0600090 | |
| Disease | balding measurement | SP3 PDE3A MPDZ BMP7 SLX4IP ULK4 KIAA2012 DYRK2 REV3L LRP6 PAM L3MBTL3 HDLBP | 5.20e-03 | 792 | 213 | 13 | EFO_0007825 |
| Disease | hair colour measurement | DNAJB12 FREM2 BMP7 NGEF REV3L PRDM7 IGHMBP2 LRP5 PCNX1 L3MBTL3 CPNE7 | 5.33e-03 | 615 | 213 | 11 | EFO_0007822 |
| Disease | vitamin D measurement, COVID-19 | 5.35e-03 | 49 | 213 | 3 | EFO_0004631, MONDO_0100096 | |
| Disease | Hereditary Diffuse Gastric Cancer | 5.60e-03 | 293 | 213 | 7 | C1708349 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.66e-03 | 50 | 213 | 3 | EFO_0022247 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | SNRK ZNF518A CNTNAP5 PLEKHA5 USH2A ARAP2 TANK TTC28 ARID4A ELP1 REV3L BICRAL NFAT5 | 5.70e-03 | 801 | 213 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | amygdala volume change measurement | 5.82e-03 | 16 | 213 | 2 | EFO_0021490 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 6.02e-03 | 225 | 213 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | Adenoid Cystic Carcinoma | 6.03e-03 | 100 | 213 | 4 | C0010606 | |
| Disease | calcium measurement | NCOA6 PDE3A ZCCHC2 SERPINA1 CGN CHD8 ABCC6 MACF1 CGNL1 UBASH3B L3MBTL3 | 6.20e-03 | 628 | 213 | 11 | EFO_0004838 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QNNEGTPTQKTARLF | 206 | Q8N6Q1 | |
| QQKNIIFATGISEPS | 126 | A8K979 | |
| GDDPSQPQTTINKEQ | 1216 | Q09472 | |
| TAQQITTPGAQQKVA | 2996 | Q96L91 | |
| QSAPVQKNDSVVSVG | 1536 | A6H8Y1 | |
| QVSKSQEILSQGNPF | 121 | Q9HCK8 | |
| NTTQLVQDDQVKGPL | 46 | P29374 | |
| SEQPVNQSTQISENK | 1361 | Q68DQ2 | |
| ATQEKSQEELPTTNN | 611 | Q8N7X0 | |
| TLNQPDSQLQLTTGN | 126 | P01009 | |
| EVAVETTTPKQGQNL | 976 | Q9UIG0 | |
| QQGTDPLVLAVQSKE | 221 | Q8N556 | |
| EKLSGVQLSPGNQQE | 66 | Q155Q3 | |
| NSIKNDLSQGIQPVQ | 106 | O75843 | |
| LNPQAQKQVGLATSS | 151 | Q92793 | |
| EGIPVKQDSLSSQNQ | 171 | P01024 | |
| KQDSLSSQNQLGVLP | 176 | P01024 | |
| EGSLLINNPNKTQDA | 81 | Q8IWV2 | |
| VIDPNNAAVLQSSGK | 561 | P19021 | |
| SLPNKVTELSDQQDQ | 116 | Q8N302 | |
| NEGNTSEITPQINSK | 206 | Q9NZW4 | |
| VSQTNIQNLKGLNSP | 711 | Q4L235 | |
| NDKSTTPNGTININE | 936 | Q8WZ64 | |
| SEPKQEPTNQNLSIS | 76 | Q9C0I3 | |
| IQPSLNSVNEGGQKI | 1101 | P11532 | |
| LLEQPQAEAKVNGTT | 3596 | P11532 | |
| NVSQLKEGTQPENSQ | 856 | Q9NQ90 | |
| QLSVETLDGQSINPK | 246 | P18075 | |
| QAEKSNQVSIAGQPA | 176 | Q9H694 | |
| PDNLNASIESQGQIK | 181 | Q7L4S7 | |
| NNVQSQDPQVSTKTG | 846 | Q9NRL2 | |
| PQTDSVIQNSENIKA | 1291 | Q9NZN5 | |
| KPSTSQSQGLTRQDQ | 161 | Q96K21 | |
| QQQKSPEQQETVLDG | 221 | Q14624 | |
| GSATETQKLNFEQQP | 131 | Q9UBG7 | |
| QIVTAVDASGSPKQQ | 36 | P49116 | |
| ENLDNPIQTVSLGQS | 1081 | P69849 | |
| QKQEVETDNGLPNTI | 196 | Q9NZL6 | |
| KSLFENQNITVIPSG | 356 | Q96JM7 | |
| LTSDNNIAQVPKQTD | 271 | Q14207 | |
| NIAQVPKQTDNNPTE | 276 | Q14207 | |
| NDKTQLIFGSVTNIP | 461 | Q9H1A4 | |
| TILNQDAQNKSPSAV | 666 | P0C881 | |
| TILNQDAQNKSPSAV | 666 | B2RC85 | |
| ENLDNPIQTVSLGQS | 1081 | Q5JPE7 | |
| LSSPGDQFEIQLTQQ | 1466 | O60309 | |
| SPQVSEENQKQLGLG | 126 | A4D1F6 | |
| LPQAQKVTTQAQSGD | 161 | Q6MZP7 | |
| LEKQPNENGVSVQNE | 676 | Q14244 | |
| KTELRSVTNGQSNQP | 6 | Q9NS87 | |
| QSNQPSNEGDAIKVF | 16 | Q9NS87 | |
| LSSPGDQFEIQLTQQ | 1466 | A6NM11 | |
| LSSPGDQFEIQLTQQ | 1466 | A6NMS7 | |
| GTDVLPSQIDQQNSV | 371 | Q5T3J3 | |
| PGNSQQATPKDNEIS | 536 | P51654 | |
| IQENQPENSKTLATQ | 1316 | Q03001 | |
| VESSLKEQGQVPLNS | 4176 | Q03001 | |
| KEQGQVPLNSTALQD | 4181 | Q03001 | |
| QKITLASNNSLSGQP | 1941 | Q5HYC2 | |
| VDNSVPQIAVNKGAS | 1651 | Q5SZK8 | |
| NIQEQTPKRSQSQSD | 581 | Q6ZUT3 | |
| ETNNNDVAIPLTGVK | 661 | O75197 | |
| IKSNDPDTTEVNLNN | 206 | Q6P5Q4 | |
| GLTIPTLNQSDQDNS | 411 | Q53TS8 | |
| EVKAGAVNNQSRPQS | 1606 | Q3V6T2 | |
| LNKTSRQQIPESQGV | 46 | Q9H3H5 | |
| QQDGTPKSISSQQPE | 231 | Q9Y6V0 | |
| EQQQPLAQNSSGKTE | 1161 | Q15154 | |
| QGQQSTAQVKVQSRP | 821 | Q96RV3 | |
| LAGIENQSLDQTPQS | 1096 | Q14432 | |
| GNKLQVENSSLPQAD | 1086 | Q13370 | |
| VNSINKPLATLEENG | 681 | O60658 | |
| NPLTNESKQQEINSE | 571 | Q6N069 | |
| LQDNTKSSAQPENLI | 411 | P51957 | |
| GSDLANPQAQKLLTQ | 516 | Q92817 | |
| KASQTQQEDSGEQPL | 101 | Q8N2G8 | |
| ENLDNPIQTVSLGQS | 1081 | Q15155 | |
| GQEQPQAVALLVSSK | 456 | Q8N8W4 | |
| TSPLTQTTEKQGAQQ | 661 | Q0VF49 | |
| QGKTQRSQQELSPVS | 1911 | P09848 | |
| NNNVAIPLTGVKEAS | 651 | O75581 | |
| TPVAANQAKQGSLIN | 1156 | P35658 | |
| SLIASTQDKPNQQDI | 251 | O95163 | |
| TLVTENGNIESVPKQ | 256 | Q05C16 | |
| TDVKSQDVAVSPQQQ | 121 | Q96F86 | |
| LQGSSVPQDQQSTNI | 1126 | O94916 | |
| PQIQLSGQTEQTQKA | 181 | Q9UBG3 | |
| SGQLNKQENDIPTDL | 31 | Q86Y13 | |
| QKENTGQQNAIISPT | 3286 | Q9UPN3 | |
| LANSEPVGTQTAKIQ | 5476 | Q9UPN3 | |
| LQTLSTQFKQAPGQT | 521 | Q9BQG0 | |
| PNSDLQGVNVISVKD | 231 | P54886 | |
| GASTQNSNTVEPEKQ | 726 | O14522 | |
| EPSQQALGPEQKQAS | 246 | Q86UR5 | |
| DQQGLNPTTLKAIGQ | 1271 | Q14686 | |
| QIVIQNDKGQDPDST | 411 | Q9Y4D1 | |
| QNVPTEEQRTNKSTG | 476 | P46100 | |
| QQENLSSNSDGISPK | 416 | Q13535 | |
| ALEGLNQPSNESLQK | 1231 | Q14674 | |
| NQPSNESLQKVLQSG | 1236 | Q14674 | |
| VNTIGEKDTSQPQQE | 6 | Q9UIM3 | |
| KIDTPQQGSIQDINH | 6 | Q9UHA7 | |
| LQGTLVIQNPQTSDS | 2586 | Q6WRI0 | |
| TENSLANENQQPIKS | 961 | Q8NHM5 | |
| QNTENKPTGEFAQEI | 461 | A2AJT9 | |
| VISASLGTAQPQQEK | 656 | Q6AI39 | |
| KNNVAGQTSIQTLVP | 36 | P51878 | |
| GQTSIQTLVPNTDQK | 41 | P51878 | |
| NSQGATPAAIEKAVQ | 946 | P12109 | |
| PTTNISREKNQGFQD | 1896 | Q8TD26 | |
| SNTQATPDLLKGQQE | 531 | Q0VF96 | |
| TPDLLKGQQELTQQT | 536 | Q0VF96 | |
| SATLTQNPEKLQQLG | 431 | Q8N8A6 | |
| TVTTKNQNRGNPAVS | 1716 | Q9Y6R7 | |
| PPLQGEISQTQENSK | 826 | Q8IW35 | |
| KSDPSVALLQQAQGQ | 41 | Q9UBL6 | |
| LIESLNQKPQTAGDQ | 46 | Q9NXW2 | |
| IKQNPNTQSLSQTGT | 461 | A8MPP1 | |
| QDTVELQNQKSSAPV | 546 | Q5VT06 | |
| PSNEVNLLDSKTIQG | 26 | P29320 | |
| GPLTQKQNGLQTTEA | 96 | Q8WXS3 | |
| SNSKETTPLAQNAVQ | 531 | Q5U623 | |
| SQAFQGKNSPQVLSE | 236 | Q8NA82 | |
| INADKNISSAQIVGP | 286 | P53990 | |
| GQLFQKSVDAAPTQQ | 516 | Q12912 | |
| APTDQGTQTEALQQL | 401 | Q00013 | |
| FLQNTEGIEPTVKQS | 2996 | Q9NYC9 | |
| QAQALGITLTPKQAQ | 1271 | A6NE01 | |
| SSTVQKQNEPGLQTE | 156 | Q8IYL3 | |
| KDQTNQQVDGSQLPI | 1191 | Q99590 | |
| GDNKTSQPITLTVEN | 191 | Q58EX2 | |
| DNSNKRTVLTTQPNG | 96 | Q92630 | |
| QLPLLEKTSNNTGEA | 2811 | Q8TDX9 | |
| SNIKLNQSSPDNVTD | 591 | Q08AD1 | |
| QPKDLISVQQGSLGN | 521 | Q8WYK1 | |
| GQVGDANINTQDPKI | 601 | Q2NL67 | |
| FLSQSQGQEAQTELP | 16 | P05451 | |
| SKVIDQLNGQLDPST | 411 | Q8IWE5 | |
| QISSQPQGETKEVSQ | 981 | Q9NXL9 | |
| TNKQIQFNPGQTTAT | 1826 | P0C091 | |
| QNTAEVQKVQLTGEP | 146 | P15151 | |
| QIQTPPDAGKLNSEN | 361 | Q5VWG9 | |
| EKENTSVLQQNPSLS | 266 | Q7Z7C8 | |
| QVNISNSQGSLITDP | 2411 | O75445 | |
| QSPVQDQDKSQLSGR | 361 | P78332 | |
| PNGSVETKNLEQILN | 211 | Q13033 | |
| SSIQNSDNDLPVVQG | 521 | Q14134 | |
| PGITSAVNKINNIDN | 231 | Q32P41 | |
| ASQNKVQALSLPETQ | 381 | B4DYI2 | |
| EVSQLEGSLQQPKAQ | 836 | Q9UPR3 | |
| TSVVGNFQEKNQRPT | 101 | A6NC51 | |
| GGEPQSQKSTEQQLA | 161 | P0C7N4 | |
| PGKFNEVSSQQAAIQ | 116 | Q9BRQ8 | |
| NQSEQGIKEPQLDAS | 916 | Q6T4R5 | |
| QVAESGSPAQLLAQK | 1476 | O95255 | |
| QKAQEAINNSVGSPS | 121 | Q96NG3 | |
| SSIQGLPTNVKDQVQ | 346 | O60664 | |
| SSSLEDQNTVNGPVQ | 3046 | Q96Q15 | |
| SQDNGKSVNEPLTLN | 91 | Q8N5V2 | |
| TPNLLNTSDSEQAQK | 136 | Q9NQW5 | |
| GKLTSQQTVEPAQNQ | 101 | Q5FBB7 | |
| NPQLESNEGQAVNSK | 141 | Q6UWV7 | |
| GKLNIQSPLTSQENS | 116 | O75182 | |
| SENNETINHIIPNGK | 576 | P53794 | |
| QGIDPIASAIQNLKT | 291 | Q92844 | |
| QSVPTTNLEVKNGVN | 261 | Q2Y0W8 | |
| IDPQNGLSFSSVKVQ | 666 | Q9NRH2 | |
| SESSGQQNQKIPQLP | 311 | Q96KW2 | |
| TQVQEKATSLPNNVA | 1851 | Q9NRC6 | |
| EKVNQTQPEDTSGQQ | 241 | Q5VYV7 | |
| SSKVQGLDPLQDLQN | 996 | Q8N961 | |
| QKPSASLSQLESQNQ | 1041 | Q9P2M7 | |
| ETVQKFQSIPAQSGQ | 396 | P53675 | |
| SNELGFIVKQVSSQP | 161 | Q9BXN2 | |
| QPQDEKAEGLINVSN | 441 | Q969H4 | |
| DPITKSASQVVGLNQ | 866 | Q9C0B9 | |
| SNPGQTERLQEFSQK | 376 | O75312 | |
| VEDGSLPQVSQQLQT | 81 | Q969E8 | |
| NTITDLQPSVKGVNN | 781 | Q5W0Q7 | |
| NEAQGKTVSQNQPDV | 156 | Q9ULJ3 | |
| PSNSENLQNKETEPT | 1451 | O75970 | |
| GLPSKNLTVSQNQSE | 246 | O15374 | |
| KQSSVAEEVGLLPQQ | 431 | Q9UH99 | |
| QKETSQIDGPSLNNT | 2261 | O60673 | |
| QTPNADQGAQAKIAS | 356 | Q12816 | |
| PSNVQQGSNVSDEKT | 721 | Q0IIM8 | |
| TPKLGNEDFNSVIQQ | 111 | Q8NI35 | |
| VRSAQGQPASKEQQA | 841 | P38935 | |
| NFLQNVEGTKSSQPL | 961 | Q6ZVD7 | |
| KENGLSTSQQVPAQR | 436 | Q08AE8 | |
| GQLPNLQTVTVNSID | 516 | Q02447 | |
| ESLINSGFSNKPVVQ | 826 | Q9BX26 | |
| VNSETLKIGDLTPQN | 1006 | O60281 | |
| QSPQSLIVQEGKNLT | 26 | A0A0B4J273 | |
| DSTPNLQQETSQDKP | 911 | Q68DE3 | |
| IQGRNTSPNVSVQKS | 1906 | Q68DE3 | |
| DDQQVKQNSPSLSVQ | 26 | P04437 | |
| TVNNTNKQEGFAVPA | 1036 | Q2KHR2 | |
| QQPQTQEKTSNSLTE | 851 | Q12888 | |
| SDQQNIKVPGNLTSV | 586 | Q02763 | |
| QTNNQEPIKVATLST | 181 | Q9Y279 | |
| ASSLQKDNVPSNQII | 1166 | Q6AHZ1 | |
| LETNLGQPTIQSFEQ | 136 | P13726 | |
| LIGALQTETDPNNTQ | 666 | Q86X10 | |
| QVSKSNNPEDGVQAP | 2186 | Q96AY4 | |
| GILQSEDKQLQPSVS | 66 | Q49AG3 | |
| NPGDVSLNNISTQSK | 1131 | Q86YA3 | |
| LQGESSNSIKNQELP | 161 | A6NK53 | |
| ILNQPSTQIVANAKG | 96 | Q99541 | |
| PGQEVLNQLDVKTSS | 26 | Q8WUA4 | |
| QGQRQSLSKTEPTQS | 676 | Q8NEE8 | |
| AGPSNLKSNISSQQV | 106 | Q9H0W7 | |
| QLQGLSPQNSKDFVQ | 586 | Q8TF42 | |
| QQPNANTTGKEQLVT | 1281 | Q70CQ4 | |
| KDDGNQPQDQITITG | 1091 | Q00341 | |
| PSSTISEQQLQRQEG | 6 | Q502W6 | |
| DPSILSAGQSQQQEN | 116 | Q9HBM0 | |
| TSILPEKGVAALQNN | 66 | Q9C040 | |
| KLQPSSSQSLDVQNI | 501 | Q86XD8 | |
| VSPQSLQGKTLSQDE | 606 | Q9HAU0 | |
| LDQEQQLKSAQSPST | 116 | Q14669 | |
| PQQNFLQGKTSSVVE | 66 | Q9BR84 | |
| QILKVSSENSNPEQD | 401 | Q6S545 | |
| DLQAQSKGNPEQTPV | 101 | P04004 | |
| DNSVSPVNENQIESK | 906 | P51784 | |
| NQQVPENTEELGQTK | 306 | Q9NXG2 | |
| VNESAVSNESQPQLK | 56 | O95405 | |
| SGPQDSKELLQNSQS | 306 | Q96C45 | |
| PEQGTNEKSNSQVPQ | 461 | Q9UNY4 | |
| KEGVTNPSNSSQQAL | 26 | A6NNM8 | |
| PNFQQTGSKLLSNVA | 1176 | Q9BYP7 | |
| ATVAQKNPGSVAENN | 26 | P20591 | |
| QGEAVSNIQENTQTP | 146 | Q13765 | |
| QDPLKTNSQLDTSIQ | 1426 | B2RTY4 |